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1. Summary
It is of pivotal importance for every organism to maintain the genomic stability since 
mutations in the genome can lead to the onset of many kinds of diseases like cancer. 
The DNA is exposed every day to a high amount of oxidative agents derived from en-
dogenous as well as exogenous sources. One of the best-characterized and most abun-
dant DNA lesion arising from oxidative stress is 7,8-dihydro-8-oxoguanine (8-oxo-G). 
The mutagenic potential of this lesion is given by its ability to form a Hoogsteen base 
pair with adenine (A). If the 8-oxo-G is not removed before the cell undergoes replica-
tion replicative DNA polymerases preferentially incorporate the wrong A instead of 
the correct C opposite the lesion. Consequently, that can lead to the formation of G:C-
>T:A transversion mutations – a frequently found lesion in different types of cancer. 
To counteract the deleterious potential of 8-oxo-G nature has evolved pathways to 
repair 8-oxo-G lesions. The MutY homologue DNA glycosylase (MutYH) recognizes and 
removes an A mispaired to 8-oxo-G and subsequently the nicked template can be cor-
rectly bypassed by DNA Pol l. The recruitment of DNA Pol l to chromatin was shown 
to be modulated by interplay of phosphorylation and ubiquitination. Until now it was 
not clear by which mechanisms MutYH is regulated.
In the present thesis work it is shown that MutYH is ubiquitinated by the E3 ligase 
Mule. Ubiquitination of MutYH targets the protein for proteasomal degradation but 
also regulates its subcellular localization. An ubiquitination deficient mutant of MutYH 
is predominantly bound to chromatin with respect to the wildtype. Consistent with 
its role in base excision repair (BER) the mutation frequency in cells with decreased 
MutYH levels is elevated upon exposure to KBrO3, while cells with increased levels of 
MutYH are able to cope better with oxidative damage. Taken together the tight regula-
tion of MutYH is of great importance to guarantee the correct and fast repair of 8-oxo-
G lesions since already small differences in the protein level can have deleterious im-
plications for the genomic stability.
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2. Zusammenfassung
Es ist für jeden Organismus von größter Bedeutung die genomische Stabilität zu erhal-
ten, da bereits einige wenige Mutationen im Erbmaterial zu Erkrankungen wie Krebs 
führen können. Die DNA ist jeden Tag einer großen Menge an oxidierenden Substanzen 
ausgesetzt, die sowohl endogenen als auch exogenen Ursprungs sein können. Eine 
der am besten untersuchten und am häufigsten vorkommenden DNA Schädigungen 
ist 7,8-dihydro-8-Oxoguanine (8-oxo-G), das meistens durch oxidati ven Stress verur-
sacht wird. Diese Schädigung führt besonders häufig zu Mutationen, da sie in der Lage 
ist, ein stabiles Hoogsteen Basenpaar mit Adenin (A) zu bilden. Die Wahrscheinlich-
keit, dass das falsche A als Gegenstück zu 8-oxo-G eingefügt wird ist sehr hoch, wenn 
die DNA Schädigung nicht vor der Zellteilung entfernt wird, da die replikativen DNA 
Polymerasen bevorzugt A einfügen. Als Konsequenz werden G:C->T:A Transversions-
mutationen generiert, die sehr häufig bei Krebs-Patienten identifiziert wurden. Um 
das Auftreten dieser Mutationen zu verhindern hat die Natur verschiedene Reparatur-
mechanismen entwickelt. Die DNA Glycosylase MutYH erkennt und entfernt ein A, das 
fälschlicherweise gegenüber von 8-oxo-G integriert wurde. Der daraus resultierende, 
geschnittene DNA Strang wird anschließend von der DNA Pol l korrekt wieder aufge-
füllt. Die Rekrutierung von DNA Pol l an das Chromatin wird durch ein Zusammenspiel 
von Ubiquitinierung und Phosphorylierung reguliert. Bisher war es allerdings nicht be-
kannt wie die Regulation von MutYH erfolgt.
In der hier vorgelegten Dissertationsarbeit wird gezeigt, dass MutYH von der E3 Ligase 
Mule ubiquitiniert wird. Die Ubiquitinierung von MutYH führt einerseits zu der prote-
asomalen Degradierung und reguliert andererseits auch die Lokalisierung von MutYH 
in der Zelle. Im Vergleich zum Wildtyp liegt eine Ubiquitinierungs-defiziente Mutante 
von MutYH vorwiegend ans Chromatin gebunden vor. In Übereinstimmung mit der 
Rolle, die MutYH in der Basen Excisionsreparatur (BER) spielt, kann gezeigt werden, 
dass Zellen in Abhängigkeit von der MutYH Konzentration besser oder schlechter mit 
oxidativem Stress umgehen können. Zellen mit niedrigerem MutYH Level zeigen eine 
höhere Mutationsfrequenz, wohingegen Zellen mit mehr MutYH weniger Mutationen 
aufweisen. Zusammenfassend kann gesagt werden, dass eine sehr genaue Regulierung 
von MutYH notwendig ist um die Reparatur von 8-oxo-G schnell und korrekt zu ge-
währleisten. Schon geringe Änderungen des Protein-Spiegels können schwerwiegende 
Konsequenzen für die Stabilität des Genoms haben.
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3. Introduction
3.1. DNA damage
DNA damage is the source of many types of cancer and diseases related with aging. 
Every organism is exposed to high numbers of different factors attacking the integrity 
of DNA, either arising from endogenous or exogenous sources. Physical and chemical 
agents can cause DNA damage as well as spontaneous reactions, mostly hydrolysis, 
leading to deamination and formation of abasic sites (1,2). A substantial amount of 
reactive oxygen species (ROS) is generated endogenously as a byproduct of oxidative 
respiration, thus the mitochondria are the main producers of ROS. Electrons leaking 
from the electron transport chain can directly go over to oxygen molecules (3) and 
cause thereby the formation of very reactive oxygen radicals.
As soon as ROS are produced they can react with many macromolecules like proteins, 
lipids and DNA molecules and cause oxidative damage (4,5). The reaction of oxygen 
radicals with DNA leads to the formation of different DNA base products (Figure 1). 
Among those 7,8-dihydro-8-oxoguanine (8-oxo-G) is the most abundant, but also the 
best-characterized DNA lesion.
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Figure 1: DNA base products.
Reproduced from (4).
Taken together the amount of DNA damage is estimated to be about 1000-7000 le-
sions per cell and day (6). DNA lesions can lead to the generation of mutations or chro-
mosomal aberrations that are related to an increased risk of cancer. 
Especially the base guanine (G) is affected by the constant exposure of genomic DNA to 
oxidation reactions. Guanine has the lowest redox potential making it very susceptible 
to oxidative stress (7). Therefore the formation of 8-oxo-G occurs often under oxida-
tive conditions. The pairing of the lesion with adenine (A) causes G:C->T:A transversion 
mutations if left unrepaired (8). In case these mutations occur in proto-oncogenes it 
may cause cancer development. Greenman et al. analyzed for the first time the ap-
pearance of somatic point mutations in different cancer tissues (9). They found the 
G:C->T:A transversions as the most prevalent mutations in the coding exons of 518 
protein kinase genes in 210 human tissue samples derived from lung, breast, ovarian, 
gastric and colorectal cancers. Strikingly a study aiming to sequence small-cell lung 
cancer cells for somatic mutations came to the same conclusion. Pleasance et al. iden-
tified G:C->T:A transversion mutations to make one third of all observed somatic muta-
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tions (10). Accordingly, in the analysis of an individual cancer genome from melanoma 
cells the G:C->T:A transversion mutations were found to be the second most prevalent 
(11). Thus, it is of pivotal importance for the human body to control and repair DNA 
damages as fast and accurate as possible to avoid the onset of diseases like cancer.
3.2. Base excision repair (BER)
3.2.1. Short- and long-patch BER
Nature has evolved a large number of repair processes to mitigate the deleterious 
potential of DNA lesions. 8-oxo-G is in the first place repaired by the short- (SP-BER) 
or long-patch BER (LP-BER) (Figure 2). DNA repair is initiated by the action of  DNA gly-
cosylases, removing the lesion by incision of the N-glycosylic bond thereby creating an 
apurinic/apyrimidinic (AP) site. This site is further targeted by the apurinic/apyrimidin-
ic endonuclease 1 (APE1) that generates a single strand break with a 3`-hydroxyl and a 
5`deoxyribose-5`-phosphate (5`dRP) termini (12). This intermediate is further cleaved 
by the dRP lyase activity of DNA Pol b, causing the formation of a one-nucleotide gap. 
The subsequent repair processes differ from each other regarding the size of the repair 
patch. During the SP-BER just one nucleotide is replaced by DNA Pol b and the nick is 
finally sealed by the DNA ligase III/X-ray repair cross complementing 1 protein (XRCC1) 
(13,14).
The LP-BER requires a strand displacement activity since 2-12 nucleotides are removed 
(15,16). The executing Pols are most likely DNA Pol b that incorporates the first nucle-
otide (17) and DNA Pol e or DNA Pol d that perform the following elongation steps. To 
locate the Pols at the site of damage additional factors are required. Replication factor 
C (RF-C) loads proliferating cell nuclear antigen (PCNA) onto the DNA and PCNA then 
acts as sliding clamp for the Pols. Finally the flap endonuclease 1 (Fen 1) excises the 
displaced nucleotides and the remaining nick is sealed by DNA ligase I (18,19).
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Figure 2: Short- and long-patch base excision repair. 
Reproduced from (20). For details see text.
3.2.2. The 8-oxo-G problem
The DNA is exposed to a variety of endogenous and exogenous sources of oxidative 
stress. Among the four bases especially G is vulnerable to oxidation due to its very 
low redox potential (7). The oxidation of G leads to the addition of an oxo-group to 
the carbon located at position 8 (C8) and a hydrogen to the nitrogen at position 7 
(N7) (Figure 3). The deleterious potential of 8-oxo-G can be attributed to its ability to 
mimic a thymidine (T). In the syn conformation 8-oxo-G is able to form a Hoogsteen 
base pair with A that resembles a normal Watson-Crick base pair (21). In contrast to 
that the pairing with C would require the anti conformation and subsequently lead to 
a template distortion. 
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Figure 3. Formation of 8-oxo-G and pairing with A. 
Modified from (22). For details see text.
Therefore almost all of the so far tested Pols tend to incorporate rather the wrong 
A than the correct C opposite the lesion (21,23-29) leading to the onset of G:C ->T:A 
transversion mutations. 8-oxo-G was shown to arise approximately 103 times per day 
in normal cells and up to 105 times in cancer cells (30). Given its high prevalence in can-
cers and its mutagenic potential it is of high importance for the human body to have 
effective repair mechanisms to counteract 8-oxo-G. 
Most organisms have, in analogy to bacteria evolved the so-called “GO-system” to 
counteract 8-oxo-G (31). It is a three-enzyme-based system comprising of two DNA gly-
cosylases from the BER and one dGTPase. The eukaryotic homologues are the 8-oxo-
G dGTPase (MTH1) (32) and the MutY homologue DNA glycosylase (MutYH) (33). In 
contrast to these two enzymes is the 8-oxo-G DNA glycosylase (Ogg1) not related to 
the bacterial Fpg, but is rather a functional orthologue (34,35). Ogg1 recognizes and 
removes the 8-oxo-G lesion generating a substrate for the subsequent BER. MTH1 hy-
drolyzes free 8-oxo-dGTP thereby eliminating it from the nucleotide pool and prevent-
ing its incorporation into DNA. The action of MutYH is required as soon as 8-oxo-G 
lesions are not removed before the replication cycle starts. In contrast to Ogg1, MutYH 
is directed to the new synthesized daughter strand and recognizes and removes an A 
mispaired to the lesion.
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3.2.3. The MutYH initiated long-patch base excision repair
For a long time 8-oxo-G:A mispairs were thought to be repaired by the conventional 
LP-BER. The DNA Pols d and e, involved in LP-BER, (36-38) are highly error prone in the 
correct bypass of 8-oxo-G. They incorporate in 30-50% the wrong A opposite 8-oxo-G 
instead of the correct C (39). Thus another repair pathway is needed to overcome the 
deleterious potential of 8-oxo-G. Van Loon et al. found a MutYH initiated LP-BER path-
way involving the action of DNA Pol l (Figure 4) (40). 
MutYH is recruited by the interaction with PCNA to the site of the lesion (1), recognizes 
the 8-oxo-G and excises the A (2) that got incorporated erroneously during replication. 
APE1, another PCNA interacting protein (41), is also bound to the DNA and generates 
a nicked strand (3). Next DNA Pol l inserts with the help of replication protein A (RP-A) 
and PCNA the correct C opposite the lesion (4) and an additional one-nucleotide flap. 
After dissociation of DNA Pol l Fen1 is recruited through interaction with PCNA (42,43) 
and removes the overhanging nucleotide (5). Finally PNCA mediates the binding of 
DNA ligase 1 (44,45) that seals the nick (6).
An alternative scenario can take place when DNA Pol l incorporates the wrong A op-
posite the lesion (A). In this case an inaccurate SP-BER is initiated. After DNA Pol l 
and RP-A dissociated from the repair intermediate the DNA ligaseIII/XRCC1 complex is 
recruited from PCNA (46) to ligate the nick (B). This pathway leads to the formation of 
an 8-oxo-G:A mispair (C/D) that can serve again as substrate for the MutYH mediated 
LP-BER giving the cell another chance to repair the lesion correctly thus preventing 
mutations.
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Figure 4. The MutYH initiated LP-BER. 
Reproduced from (40). For details see text.
3.3. The MutYH DNA glycosylase
MutYH is a monofunctional glycosylase, meaning it lacks an additional AP lyase activity 
(47). The glycosylase belongs to the family of helix-hairpin-helix (HhH) glycosylases and 
the encoding gene is located at the short arm of chromosome 1 (1p32.1 - p34.3). The 
catalytic domain is located in the N-terminal part of the protein containing an [4FE-4S] 
iron sulfur cluster (48,49), while the C-terminus consists of the MutT-like domain (23) 
that was shown to have an important role in substrate recognition. The 8-oxo-G lesion 
is recognized and bound mainly by the MutT-like domain (50) and the mispaired A is 
flipped out into a pocket of the active site where the glycosidic bond is cleaved (51,52). 
MutYH is spliced in a mitochondrial (53) and a nuclear form (54) since the sequence of 
the protein contains a nuclear and a mitochondrial localization signal. The exact num-
ber of different splice variants is still under debate and discussed controversial (55-59).
MutYH interacts with many proteins involved in DNA damage repair, replication and 
cell cycle checkpoints like DNA Pol λ (40), RP-A (60), the 9-1-1 complex (61,62), PCNA 
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(60,63), MSH6 (64), ATR (65) and APE1 (60) (Figure 5). This interaction can either stim-
ulate the glycosylase activity of MutYH (62,64,66) or can regulate the recruitment to 
chromatin (67).
Al-Tassan et al. identified germline mutations in patients suffering from colorectal car-
cinoma and adenoma (68). These mutations impaired the glycosylase activity dramati-
cally (69,70) and caused thereby a massive increase in mutations leading to the onset 
of cancer. Further investigations identified more patients carrying MutYH mutations, 
like missense and in-frame mutations as well as mutations leading to different splicing 
constructs (Figure 5) (71). Some of them were shown to enhance the mutator pheno-
type of human cells under conditions of oxidative stress (72). However, many muta-
tions identified in MutYH associated polyposis (MAP) patients are not characterized so 
far and their role in the development of cancer remains elusive.
Figure 5: Diagram of MutYH including three typical types of mutations identified in patients suffering 
from MAP. 
Reproduced from (73,74). For details see text.
Only a few reports are published concerning the regulation of MutYH. The protein 
levels were shown to peak in S-phase (58), what is in accordance with its predicted 
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role in replication-coupled repair (75). Apart from publications reporting MutYH to 
be phosphorylated nothing is known about posttranslational modifications (PTM) of 
MutYH. Depressed phosphorylation levels of MutYH caused a decrease in the cata-
lytic activity and thereby an enhanced mutation frequency in colorectal cancer cells 
(76,77). Further in vitro studies also confirmed the importance of phosphorylation for 
the glycosylase activity of MutYH (78,79).
In the following review “MutYH DNA glycosylase: the rationale for removing undam-
aged bases from DNA”, all aspects of MutYH are discussed in more detail.
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3.4. Review : “MutYH DNA glycosylase: the rationale for removing   
  undamaged bases from DNA”
 Enni Markkanen, Julia Dorn and Ulrich Hübscher                                              
 Frontiers in genetics, 2013, 4, 18. 
 The following review, which I co-authored, is a summary of all aspects              
 concerning MutY and MutYH DNA glycosylases.                 
 An update of the literature published since February 2013 is summarized   
 following the original publication.                        
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Maintenance of genetic stability is crucial for all organisms in order to avoid the onset
of deleterious diseases such as cancer. One of the many proveniences of DNA base
damage in mammalian cells is oxidative stress, arising from a variety of endogenous
and exogenous sources, generating highly mutagenic oxidative DNA lesions. One of
the best characterized oxidative DNA lesion is 7,8-dihydro-8-oxoguanine (8-oxo-G), which
can give rise to base substitution mutations (also known as point mutations). This
mutagenicity is due to the miscoding potential of 8-oxo-G that instructs most DNA
polymerases (pols) to preferentially insert an Adenine (A) opposite 8-oxo-G instead of
the appropriate Cytosine (C). If left unrepaired, such A:8-oxo-G mispairs can give rise to
CG→AT transversion mutations. A:8-oxo-G mispairs are proficiently recognized by the
MutY glycosylase homologue (MUTYH). MUTYH can remove the mispaired A from an
A:8-oxo-G, giving way to the canonical base-excision repair (BER) that ultimately restores
undamaged Guanine (G). The importance of this MUTYH-initiated pathway is illustrated
by the fact that biallelic mutations in the MUTYH gene are associated with a hereditary
colorectal cancer syndrome termed MUTYH-associated polyposis (MAP). In this review,
we will focus on MUTYH, from its discovery to the most recent data regarding its cellular
roles and interaction partners. We discuss the involvement of the MUTYH protein in the
A:8-oxo-G BER pathway acting together with pol λ, the pol that can faithfully incorporate
C opposite 8-oxo-G and thus bypass this lesion in a correct manner. We also outline
the current knowledge about the regulation of MUTYH itself and the A:8-oxo-G repair
pathway by posttranslational modifications (PTM). Finally, to achieve a clearer overview of
the literature, we will briefly touch on the rather confusing MUTYH nomenclature. In short,
MUTYH is a unique DNA glycosylase that catalyzes the excision of an undamaged base
from DNA.
Keywords: MUTYH, MUTYH-associated polyposis (MAP), MYH, mutY, DNA polymerase beta and lambda,
base-excision repair (BER), DNA glycosylases, 8-oxo-guanine
INTRODUCTION
Cellular DNA is constantly under attack of damaging agents, such
as reactive oxygen species (ROS), that derive from a multitude of
exogenous and endogenous sources (reviewed in Van Loon et al.,
2010). One of the main consequences of ROS impact on DNA
is the formation of 8-oxo-G, a frequent DNA lesion estimated
to arise around 1000–7000 times per cell per day (Collins, 1999;
European Standards Committee on Oxidative DNA Damage
(ESCODD), 2003; Gedik and Collins, 2005; Friedberg, 2006).
To counteract this heavy burden of 8-oxo-G lesions, a multi-
component system involving a plethora of enzymes has evolved
both in bacteria and mammals. 8-oxo-dGTP, which arises upon
oxidation of the nucleotide pool, is hydrolyzed by the enzymes
MutT/MTH1, which therefore prevent incorporation of 8-oxo-
dGTP into nascent DNA. When a C:G base pair is oxidized to
C:8-oxo-G, the enzyme Fpg (also known asMutM)/OGG can cat-
alyze the removal of 8-oxo-G from these base pairs. Furthermore,
other proteins such as the mismatch-repair pathway component
MutS/MSH2, or the Nei endonuclease VIII/NEIL1 and NEIL2
have been shown to protect the genome from the mutagenic
consequences of 8-oxo-G damage. Finally, A:8-oxo-G base pairs
are a substrate for MutY/MUTYH, which is the protein in the
focus of this review. Information on the contribution of all of the
other factors to genetic stability can be found in these detailed
reviews (Lu et al., 2006a; Tsuzuki et al., 2007).
In the syn conformation, 8-oxo-G functionally mimics the
base pairing properties of a Thymine (T), which leads to the
formation of stable A(anti):8-oxo-G(syn) Hoogsteen base pairs
(David et al., 2007). Due to this particular behavior of 8-oxo-G,
most pols often bypass 8-oxo-G lesions inaccurately by incor-
rectly inserting an A instead of the correct C, therefore giving
rise to A:8-oxo-G mismatches (Maga et al., 2007). If these A:8-
oxo-G mismatches are not repaired before the next round of
replication, they can generate CG→AT transversion mutations
that have the potential to transform cells and lead to cancer
(Greenman et al., 2007). Oxidative damage to C:G base pairs in
DNA leads to the generation of C:8-oxo-G base pairs. The major-
ity of 8-oxo-G from these base pairs is recognized and removed
from the genome by the OGG1 DNA glycosylase, which initiates
a canonical short-patch base-excision repair (SP-BER) pathway
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Markkanen et al. The genome cleaner MUTYH glycosylase
involving apurinic endonuclease 1 (APE1), pol β, XRCC1, and
DNA ligase III. This results in the restoration of the original
C:G base pair [see Figure 1, Dianov et al., 1998; Fortini et al.,
1999; Pascucci et al., 2002; Fromme et al., 2003 and reviewed in
Van Loon et al. (2010)]. However, a problematic situation may
arise when the replication fork encounters an 8-oxo-G. Such a
scenario can result from either a failure of OGG1 to repair all
8-oxo-G lesions before the start of replication, or from oxida-
tive stress during the S-phase. In contrast to UV-induced lesions,
for instance, that present a block to the replicative pols (reviewed
in Lehmann, 2002), 8-oxo-G is not considered a blocking lesion
per se (Shibutani et al., 1991; Mozzherin et al., 1997; Avkin and
Livneh, 2002). Nevertheless, it has been found that replicative
pols (such as the Klenow fragment of E. coli pol I, calf thymus
pol α and pol δ) show transient inhibition of chain extension 3�
to 8-oxo-G and extend promutagenic A:8-oxo-G base pairs more
efficiently than the correct C:8-oxo-G base pairs (Shibutani et al.,
1991; Einolf and Guengerich, 2001). Also, human pol δ has been
demonstrated to stall at sites of 8-oxo-G lesions (Fazlieva et al.,
2009). Very recently, we have proposed that a switch between
the replicative pol δ and the repair pol λ promotes the correct
bypass of 8-oxo-G lesions during replication (Markkanen et al.,
2012a). Nevertheless, oxidative stress in context of DNA replica-
tion can result in the generation of A:8-oxo-Gmispairs, which are
FIGURE 1 | MUTYH-initiated BER of A:8-oxo-G lesions.When ROS attack
DNA, they lead to the formation of C:8-oxo-G base pairs through oxidation of
G. Left column: These can be recognized by OGG1, which excises the
8-oxo-G and incises the resulting AP-site by β-elimination, giving rise to a
3�ddR5P and a 5�P residue. This 3� sugar phosphate is then removed by
APE1, yielding in a 1 nucleotide gap with a 3�OH and a 5�P. Subsequently, pol
β catalyzes the insertion of a G opposite the templating C in this SP-BER
pathway, and ligation by XRCC1/DNA ligase I leads to restoration of an intact,
correctly base-paired double-stranded DNA again.Middle column: If the
C:8-oxo-G base pairs are not recognized before S-phase by OGG1, or they
arise through oxidation in S-phase, the replicative pols will often incorporate a
wrong A opposite 8-oxo-G, giving rise to A:8-oxo-G mispairs. If these are not
corrected, another round of replication will lead to a CG→AT transversion
mutation. Right column: The A:8-oxo-G base pairs can be recognized by
MUTYH, which catalyzes the excision of the wrong A from opposite 8-oxo-G,
leading to the formation of an AP site. This AP site is further processed by
APE1, which results in a 1 nt gap with 3�OH and 5�dRP moieties. The
incorporation of the correct C opposite 8-oxo-G and one more nucleotide is
performed by pol λ in collaboration with the cofactors PCNA and RP-A, thus
performing strand displacement of the downstream DNA strand. FEN1
cleaves the 5� flap, leading to a 5�P moiety, which can be ligated by DNA
ligase I to yield an intact C:8-oxo-G containing double-stranded DNA. This
C:8-oxo-G is then again substrate for OGG1-mediated removal of 8-oxo-G
(left column).
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substrates for MUTYH. As a monofunctional DNA glycosylase,
MUTYH catalyzes the excision of the A mispaired with 8-oxo-
G. Thus, MUTYH is a unique glycosylase as far as it removes an
undamaged base from opposite a DNA lesion, instead of removing
the damaged base. The steps following MUTYH-initiated repair
of A:8-oxo-G lesions are discussed in more detail in the follow-
ing. As this review is focused on MUTYH, the interested reader
is referred to a detailed excellent review for more information on
the cellular DNA glycosylases in general (Jacobs and Schar, 2012).
DISCOVERY
MutY, along with the other 8-oxo-G repair enzymes FpG and
MutT, is phylogenetically an ancient protein, emphasizing the
importance to cope correctly and efficiently with oxidative dam-
age for living organisms (Jansson et al., 2010). MutY homologues
have been identified in many organisms, both in prokaryotes as
well as in eukaryotes. They all share the unique function of being
able to remove an A that is incorrectly paired with 8-oxo-G, G,
C, 5-hydroxyuracil (5-OH-U), or 2-hydroxyadenine (2-OH-A),
as specified later on.
DISCOVERY OF MutY IN E. coli
The first mutators in E. coli strains were described about 60 years
ago (Treffers et al., 1954) based on the observation that some
strains showed an altered antibiotic resistance. These findings
were used to engineer a systematic screening for mutators with
certain properties. Nghiem et al. used Lac− E. coli strains trans-
formed with constructs encoding for β-galactosidase, each inac-
tivated by a specific point mutation. When reverted back to Lac+
the specific base substitution reactivating the β-galactosidase
could be identified. A strain with an increase in C:G→A:T
transversion mutations revealed the so far not described locus
called mutY to be responsible for the observed mutator pheno-
type (Nghiem et al., 1988).
In addition to the mutY, another locus, called mutM, was
found to cause a change from C:G→A:T (Cabrera et al., 1988)
when mutated and was later identified to encode the for-
mamidinopyrimidine DNA glycosylase (Fpg) (Michaels et al.,
1991). Neither mutY nor mutM strains showed a very pro-
nounced phenotype on their own, but double mutant strains
expressed an extremely high mutation rate (Michaels et al.,
1992a). Mutations in mutY and mutM exclusively enhanced one
type of transversion mutation, while neither frameshifts nor dele-
tions were found, in contrast to what had been reported for other
mutators (Nghiem et al., 1988).
It had been shown that the correction of A:Gmispairs in E. coli
extracts could occur by two distinct pathways: the methylation-
dependent mutHLS mismatch-repair pathway that recognizes a
variety of mismatches and repairs the unmethylated DNA strand,
and a second methylation-independent mechanism specific to
A:G mismatches (Su et al., 1988). Analysis of the second path-
way revealed that the mutY gene product was involved in this
novel DNA repair mechanism (Au et al., 1988). Cells defective in
the mutHLS-dependent repair but proficient for mutY were still
able to prevent C:G→A:T transversion mutations, and themutY-
dependent repair was dominant if both pathways were available.
The function of the mutY gene product was finally elucidated by
purification of a protein according to its ability to repair a A:G
mismatch. The 36 kDa protein was capable of removing the mis-
paired base A from dsDNA and rendered the strand sensitive for
cleavage by apurinic/apyrimidinic endonucleases at the site of the
mismatch (Au et al., 1989). This result further underlined the
hypothesis that mutY encoded for a DNA glycosylase, termed
MutY, that initiated the repair of A:G mismatches while other
mispairs, as for example A:C, were not recognized. Further on, Su
et al. showed that MutY, with help of pol I and DNA ligase, was
able to restore specifically A:G mismatches to C:G in a sequence
independent manner (Su et al., 1988). Cloning and sequencing of
the mutY gene finally revealed that it encoded for a 350 amino
acids DNA glycosylase that could rescue the mutator phenotype
of mutY E. coli strains (Michaels et al., 1990).
DISCOVERY OF THE MAMMALIAN MutY HOMOLOG (MUTYH)
The first experiments using cell extracts showed that, in gen-
eral, humans had a repair mechanism for mismatches similar to
those of bacteria preventing the generation of mutations dur-
ing replication (Holmes et al., 1990; Thomas et al., 1991). The
analysis of human HeLa nuclear extracts revealed the existence
of two enzyme systems that could nick DNA specifically at sites
of mispaired bases (Yeh et al., 1991). One of the identified sys-
tems showed a specific substrate recognition, cleaving the DNA
at A:G mismatches and could be separated from other enzymes
by chromatography. Since this enzyme showed the same sub-
strate specificity as the bacterial MutY, Yeh et al. proposed to have
identified its human homologue (Yeh et al., 1991).
The first characterization of a mammalian homologue of
MutY was published by McGoldrick et al., who purified an
enzyme from calf thymus that was acting on A:G mismatches.
Apart from the substrate specificity they described several other
features indicating that they had indeed purified a MutY homo-
logue: An AP endonuclease activity was co-purified with the DNA
glycosylase and the antibody generated against bacterial MutY
recognized a band at the expected size and could inhibit the DNA
glycosylase activity of the purified protein (McGoldrick et al.,
1995). Based on the finding that CG→AT transversion mutations
occur often in different kinds of cancer (Hollstein et al., 1991), the
authors already hypothesized that the human MutY homologue
might be involved in cancer prevention.
A few years after the characterization of human homologue
of the 8-oxo-dGTP hydrolase MutT which removes 8-oxo-dGTP
from the nucleotide pool (Sakumi et al., 1993), Slupska et al.
succeeded in cloning and sequencing of the human mutY gene,
termed MUTYH (Slupska et al., 1996). By screening different
cDNA libraries for amino-acid sequence homologies, they iden-
tified a gene that showed 41% identity with the E. coli mutY.
The gene was 7.1 kb long, contained 15 introns and encoded
for a protein of 535 amino acids in length, which was consis-
tent with the size of the protein that had been detected in HeLa
cells (McGoldrick et al., 1995). By using in situ hybridization they
could map the gene on chromosome 1, between p32.1 and p34.3.
The current status of knowledge is that the humanMUTYH gene
codes for at least 10 different isoforms of MUTYH protein. There
are three major transcripts, α, β, and γ that differ from each
other in the 5� end sequence and are generated through alternative
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splicing (Ohtsubo et al., 2000). The transcript α3 was found to be
the originally identified MUTYH, but so far it is not entirely clear
what the functions of the different isoforms are and to which cell
compartment they are localized, as we will discuss below in more
detail.
NOMENCLATURE OF MUTYH
Currently, literature referring to the protein product of the mam-
malian MUTYH gene is rather confusing due to a diversity of
different synonyms and writing styles that have been used over
the last years. The most commonly used names are MUTYH,
MutYH, MYH, and hMYH. Here, we propose to uniformly use
MUTYH as name for this protein in mammals in order to
simplify the literature overview, because of the following rea-
sons. Firstly, MUTYH [MutY homolog (E. coli)] is the officially
approved name for the gene fromwhichMUTYHderives (HUGO
Gene Nomenclature Committee). Secondly, the official protein
name listed by leading protein databases (UniProtKB, neXtProt,
Ensembl, and Reactome) is MUTYH. Thirdly, as the protein
derives its name from the bacterial homolog mutY that was dis-
covered first, the logical extension would be the addition of an
“H” for “homolog” at the end of the protein name, which also
leads to easy recognition of homology between MUTYH and
MutY.
FUNCTION OF MutY AND MUTYH
MutY
MutY—substrate specificity
The currently known substrates for MutY and MUTYH are sum-
marized in Table 1. Analysis of the substrate specificity for MutY
demonstrated that it acts as a glycosylase on A:G, A:8-oxo-G, A:C,
and A:8-oxo-A mismatches, always removing the undamaged A
from each substrate (Michaels et al., 1992b). Lu et al. further
refined the DNA determinants and substrate specificities for the
catalytic activity of MutY, using binding and endonuclease assays
with a variety of different A-containing mismatches, and con-
cluded that DNA sequences proximal to the mismatch as well as
specific functional groups of mismatched bases dictate the recog-
nition and catalysis by MutY (Lu et al., 1995). Moreover, while
MutY bound the A:8-oxo-Gmuch tighter than A:G, its activity on
A:8-oxo-G was weaker than on A:G mismatches. Bulychev et al.
contradicted this notion in a subsequent report stating that A:8-
oxo-G appeared to be the natural substrate for MutY, as judged
by the specificity constants and the fact that the presence of an
8-oxo-group in G increased significantly the rate of removal of A
from all tested substrates (Bulychev et al., 1996). Additionally to
A:8-oxo-G, MutY was shown to bind to G:8-oxo-Gmismatches as
well, and it was capable of removing G from this substrate (Zhang
et al., 1998). The sequence context surrounding an A:Gmismatch
was shown to also significantly influence the catalytic activity of
MutY (Sanchez et al., 2003).
8-oxo-G is chemically labile toward further oxidation
into guanidinohydantoin (Sp1), spiroiminodihydantoin (Sp2),
oxaluric acid, and urea. Delaney et al. investigated the activity of
MutY on these lesions by introducing them into single-stranded
viral genomes which were replicated in E. coli proficient or defi-
cient for MutY (Delaney et al., 2007). These lesions were found
to be equally mutagenic in terms of frequency in both genetic
Table 1 | Substrate specificities of the different MutY and MUTYH
proteins.
Protein Base pair Excised References
substrate base
MutY E. coli A:G A Michaels et al., 1992b;
Lu et al., 1995; Gogos
et al., 1996; Noll et al.,
1999; Gu and Lu, 2001
A:8-oxo-G A Michaels et al., 1992b;
Lu et al., 1995; Gogos
et al., 1996; Noll et al.,
1999; Gu and Lu, 2001
A:C A Michaels et al., 1992b
A:8-oxo-A A Michaels et al., 1992b
2-OH-A:G 2-OH-A Hashiguchi et al., 2002;
Pope and David, 2005
2-OH-A:8-oxo-G 2-OH-A Pope and David, 2005
A:FapyG A Wiederholt et al., 2003
G:8-oxo-G G Zhang et al., 1998
MutY
Th. thermophilus
A:8-oxo-G A Back et al., 2006
A:G A Back et al., 2006
G:8-oxo-G G Back et al., 2006
T:8-oxo-G T Back et al., 2006
MUTYH
S. pombe
G:8-oxo-G G Doi et al., 2005
A:8-oxo-G A Doi et al., 2005
MUTYH mouse A:8-oxo-G A Tominaga et al., 2004;
Pope and David, 2005
A:G A Pope and David, 2005
2-OH-A:G 2-OH-A Pope and David, 2005
2-OH-A:8-oxo-G 2-OH-A Pope and David, 2005
MUTYH calf A:G A McGoldrick et al., 1995;
Parker et al., 2000
A:8-oxo-G A McGoldrick et al., 1995;
Parker et al., 2000
A:C A McGoldrick et al., 1995;
Parker et al., 2000
G:8-oxo-G G Parker et al., 2000
T:8-oxo-G T Parker et al., 2000
C:8-oxo-G C Parker et al., 2000
MUTYH human A:8-oxo-G A Slupska et al., 1999;
Shinmura et al., 2000;
Gu and Lu, 2001
A:G A Slupska et al., 1999;
Shinmura et al., 2000;
Gu and Lu, 2001
2-OH-A:G 2-OH-A Ushijima et al., 2005
backgrounds and to yield similar mutation spectra, suggesting
that MutY does not play a role in the excision of these bases.
Interestingly Sp1 and Sp2 were more toxic to the cells that were
proficient in MutY.
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2-hydroxyadenine (2-OH-A) is a lesion that is induced by
Fenton-type ROS and is produced for instance by H2O2 treat-
ment of culturedmammalian cells (Jaruga andDizdaroglu, 1996).
Incorporation of 2-OH-dATP into the bacterial genome by pol
III was shown to yield slightly increased mutant frequencies in
a MutY deficient background in E. coli, suggesting that the pro-
cessing of 2-OH-A damage possibly also involves the action of
MutY (Kamiya and Kasai, 2000a). However, follow-up work by
the same authors showed that, irrespectively of the base in the
complementary strand, DNAwith 2-OH-A presented a very poor
substrate for MutY, and therefore illustrated that neither MutY
nor Fpg seemed to play a role in 2-OH-A removal from DNA
(Kamiya and Kasai, 2000b). Another result by Hashiguchi et al.
again reassessed this finding and they reported that MutY indeed
bound to 2-OH-A in duplex with G, A, or C and displayed a DNA
glycosylase activity capable of removing 2-OH-A from 2-OH-A:G
mismatches, which was dependent on the C-terminal domain of
the protein (Hashiguchi et al., 2002).
FapyG is a DNA lesion that arises from oxidative stress by ring-
fragmentation of the purine base. MutY excised A from A:FapyG
mismatches, and this reaction was faster than the removal of
A from A:G, but still slower than that from A:8-oxo-G in vitro
(Wiederholt et al., 2003).
One group reported that MutY efficiently recognized 7-deaza-
2′-deoxyadenosine (Z) and its non-polar isostere 4-methylindole-
beta-deoxynucleoside (M) opposite 8-oxo-G and G in DNA,
with a preference for M:8-oxo-G over Z:8-oxo-G mispairs
(Chepanoske et al., 2000b). This finding was contradicting a pre-
vious report, in which Z:G mispairs were neither bound nor
processed by MutY (Lu et al., 1995).
Lu et al. showed that MutY competes with and inhibits
endonuclease VIII on its natural substrate, the hydroxyurea
(hoU):A mismatch (Lu et al., 2006b).
A MutY variant from Thermus thermophilus processed A:8-
oxo-G, G:8-oxo-G as well as T:8-oxo-G and A:G mismatches,
but in contrast to other MutY variants, was shown to harbor a
bifunctional glycosylase activity (Back et al., 2006).
MutY—enzymatic activity
The cloning of E. coli MutY revealed that it shared significant
sequence homology to the bacterial endonuclease III (EndoIII),
which acts on damaged base pairs (Michaels et al., 1990). MutY
was shown to be an iron-sulfur (Fe-S) cluster protein containing
both N-glycosylase and a 3′ AP endonuclease activity (Tsai-Wu
et al., 1992). Initially there was some confusion regarding the
enzymatic activity of MutY. While some reports stated that MutY
also acted as an endonuclease on AP sites, therefore functioning
as a bifunctional glycosylase (Tsai-Wu et al., 1992; Lu et al., 1995,
1996; Gogos et al., 1996; Manuel and Lloyd, 1997), Zharkov and
Grollman showed that MutY does not harbor any AP lyase activ-
ity (Zharkov and Grollman, 1998). They hypothesized that the
previous observations for the observed AP-activity were rather
caused by heat-induced cleavage of the AP site and not due to an
actual enzymatic activity. Moreover, this report suggested that the
tight binding of MutY to its DNA substrate prevented the access
of another bacterial glycosylase, the formamidopyrimidine-DNA
glycosylase (Fpg), to the substrate. Consequently, MutY seemed
to prevent a possible generation of a DNA double-strand break
(DSB) by Fpg and thus possibly to play a role in the regulation
of BER.
MutY—catalytic mechanism
When considering the catalytic activity of MutY (or any other
DNA glycosylase), it is important to keep in mind that the
catalytic cycle can be roughly subdivided into different stages,
namely (1) recognition and binding of the enzyme to the sub-
strate, (2) hydrolysis of the N-glycosidic bond or base-excision,
and (3) dissociation of the enzyme or release of the resulting AP
site. We have tried to structure the discussion according to these
three steps in the catalytic cycle, whenever possible.
Substrate recognition. Multiple studies elucidating the contri-
butions of the different parts of the MutY protein have been
undertaken. Proteolytic digestion of MutY with thermolysin
produced two fragments, an N-terminal one of 25 kDa and a
C-terminal one of 12 kDa, respectively (Gogos et al., 1996). While
the 12 kDa fragment did not display any detectable enzymatic
activity, it was found to play an important role in the repair of
mismatched oxidized DNA, as its deletion significantly impaired
the binding and activity of MutY on A:8-oxo-G substrates, while
it did not influence binding and cleavage of A:G substrates. On
the other hand, a similar study, generating a 26 kDa N-terminal
domain of MutY by trypsin-mediated proteolysis showed that
this 26 kDa subunit was catalytically active, contained both DNA
glycosylase and AP lyase activity, and was functionally identi-
cal with the full-length protein (Manuel et al., 1996; Manuel
and Lloyd, 1997). A 14 kDa C-terminal domain of MutY (AA
1–226) was demonstrated to be the principal determinant for
8-oxo-G specificity, as its deletion remarkably enhanced the dis-
sociation of the enzyme from A:8-oxo-G and reduced the rate of
A removal from these substrates compared to A:G mismatches
(Noll et al., 1999). This was interpreted such that the C-terminal
domain facilitated A base flipping. Also, this study found that the
C-terminal domain of MutY showed homology with MutT, sug-
gesting that it might serve in 8-oxo-G recognition. Another report
supported this view by showing that the N-terminal domain
of MutY (AA 1–226) had a 18-fold lower affinity for binding
various 8-oxo-G mismatches, a reduced catalytic preference for
A:8-oxo-G over A:G mismatches and exhibited a lower inhibi-
tion on Fpg activity than the wild-type (wt) MutY (Li et al.,
2000). These results suggested that the C-terminal domain of
the protein determines its 8-oxo-G specificity and is crucial for
mutation avoidance. The C-terminal domain was then shown to
mediate additional contacts between MutY and A:8-oxo-G con-
taining substrates that are not found in interaction with A:G (Li
and Lu, 2000), thereby promoting the efficient recognition of
substrates byMutY (Chmiel et al., 2001) and also affecting the cat-
alytic activities toward A:G mismatches (Li and Lu, 2003). Taken
together, the C-terminal domain of MutY seems to contribute
substantially to the A:8-oxo-G substrate recognition.
It is still not entirely clear, how MutY is capable to effi-
ciently recognize all its substrates from among the vast amount
of undamaged base pairs. Along this line, the Fe-S cluster present
in MutY was shown to be critical for the specific recognition of
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its DNA substrate and its enzymatic activity (Porello et al., 1998a;
Golinelli et al., 1999; Chepanoske et al., 2000a). It has also been
suggested that the relative oxidation resistance of the Fe-S clus-
ter may be an important aspect to guarantee the activity of MutY
under conditions of oxidative stress (Messick et al., 2002). K142
in MutY, earlier shown to be involved in formation of tight inter-
actions with DNA, was shown to make specific contacts with
8-oxo-G, and DNA-mediated charge transport (CT) was sug-
gested as signal to promote the binding of MutY to DNA from
a distance (Boon et al., 2002). Along this line, DNA-mediated CT
led to oxidation of DNA-bound MutY, suggesting that G radicals
provide the signal to stimulate DNA repair by the redox acti-
vation of DNA repair proteins through CT (Yavin et al., 2005).
Further substantiating this idea, Boal et al. proposed that the
rapid redistribution of proteins to the sites of DNA damage was
mediated through redox activation involving the Fe-S clusters
in proteins such as MutY and EndoIII (Boal et al., 2005; Yavin
et al., 2006). A theoretical study of the DNA damage recogni-
tion by Bacillus stearothermophilus MutY proposed that the CT
from MutY to DNA through hole transfer, which is specially effi-
cient near an 8-oxo-G, leads to the stabilization of the enzyme
in a conformation required for recognition of the lesion (Lin
et al., 2008). Examination of the charge-transfer model by atomic
force microscopy further validated this concept and emphasized
the possibility that indeed repair proteins might be recruited to
DNA lesions by DNA-mediated CT in the cellular context (Boal
et al., 2009). The authors therefore proposed a model wherein
the binding of Fe-S cluster containing DNA repair proteins (such
as MutY and EndoIII) to DNA activates them toward oxidation.
First, the formation of a guanine radical oxidizes a repair pro-
tein bound to DNA and thus stabilizes the binding of this protein.
This step is followed by the binding of a second protein near the
first one. Because also this protein gets oxidized during binding
and transfers an electron to the DNA, it will induce a DNA-
mediated CT from the second to the first protein if no damage
is present in the DNA stretch between the two binding sites. This
CT leads to reduction of the first protein and thus to its release
from DNA, because in the reduced state it has a lower affin-
ity to DNA. However, if there is a DNA lesion between the two
bound proteins, the CT does not take place (it is “blocked” by the
intervening lesion). In this situation both of the proteins remain
bound and can subsequently catalyze repair steps. Through exam-
ination of CT mutants of EndoIII the group subsequently linked
the ability of a repair protein to carry out DNA CT and its ability
to localize to damaged DNA and thus further underlined their
model (Romano et al., 2011). Taken together, the role for the
Fe-S cluster as redox cofactor to search for damaged bases using
DNA-mediated CT becomes more and more substantiated and
really presents a plausible scenario to explain the mechanisms of
full-genome search for lesions.
Base-excision. Investigations into the glycosylase activity of
MutY revealed a distinctive difference in the processing of A:8-
oxo-G compared to A:G mismatches (Porello et al., 1998b).
Hydrolysis of A from opposite 8-oxo-G was at least 6-fold faster
than from the A:G mispair. Interestingly however, MutY “lin-
gered” when excising from an A:8-oxo-G base pair and released
the product with a much slower kinetic compared to the A:G sub-
strate. This delay in substrate release might protect 8-oxo-G from
being prematurely accessed and removed by other glycosylases, as
also suggested by Zharkov and Grollman (1998). A detailed study
of the active site revealed the importance of several amino acids
involved in the glycosylase as well as DNA binding activities of
MutY (Wright et al., 1999). Bifunctional glycosylases all bear a
conserved lysine residue believed to be important for the initial
nucleophilic attack in base removal near their active site, which
is lacking in their monofunctional counterparts. To yield more
insight into the role of this residue on a structural basis, Williams
et al. investigated whether insertion of such a lysine residue into
the catalytic site of MutY had any influence on its activity. Indeed,
a point-mutation at S120K generated a MutY mutant capable of
catalyzing DNA strand scission at a rate that was similar to its
A excision activity from A:G and A:8-oxo-G substrates, and also
changed it into a bifunctional glycosylase (Williams and David,
2000). This study illustrated that the basic mechanisms of mono-
and bifunctional glycosylases were quite similar. The glycosylase
activity of MutY was shown to involve a Schiff base intermedi-
ate, characteristic for other bifunctional DNA glycosylases that
catalyze a β-lyase reaction, though no β-lyase step (per se only per-
formed by bifunctional glycosylases) could be observed (Williams
andDavid, 1998). Reduction of this Schiff-base intermediate with
borohydride resulted in the formation of a covalent MutY-DNA
adduct. To identify the residues involved in this covalent complex
formation, Williams et al. constructed different MutY mutants
and identified K142 to be the primary residue for such covalent
associations (Williams andDavid, 1999). As the DNAbinding and
enzymatic activity of the K142A mutant was comparable to that
of the wt enzyme, the formation of this covalent intermediate was
not required for removal of A and was suggested to be a conse-
quence of the unusually high affinity of MutY for the product of
its glycosylase activity. Similarly, mutation of K142 to glutamine
in MutY was shown to also abrogate its ability to form a Schiff
base with DNA, while still retaining some of its catalytic activ-
ity (Zharkov et al., 2000). Interestingly, this mutation selectively
impaired the processing of A:G base pairs, but not of A:8-oxo-
G substrates, primarily by interfering with the binding to A:G
substrates, but did not impair the catalytic activity per se, again
confirming that it was not directly involved in the catalytic step.
Using unnatural substrates to elucidate the tolerance of MutY to
different modifications of the A or the 8-oxo-G in mismatches in
an E. coli-based cellular assay, it was seen that, while modification
of A was tolerated rather well, modification of 8-oxo-G resulted
in a drastic reduction of base-excision (Livingston et al., 2008).
This led to the conclusion that the presence of 8-oxo-G is critical
for MutY to recognize A:8-oxo-G mismatches in vivo to initiate
repair. D138 and Q37 are both residues that are involved in the
catalytic mechanism of MutY-mediated A removal. Interestingly,
their substitution yielded mutants with a range of different
excision activities. Studies of these mutants demonstrated that
changes which reduced the excision activity were better tolerated
and less compromising to A:8-oxo-G repair in vivo in E. coli than
those affecting the recognition of A:8-oxo-G mismatch affinity
(Brinkmeyer et al., 2012). Therefore, this report suggested that the
recognition of A:8-oxo-Gmismatches wasmore important for the
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correct repair of these duplexes than the actual glycosylase activity
per se. Interestingly, this can be reconciled with the fact that the
release of the substrate byMutY after base-excision ismuch slower
than the actual N-glycosidic activity, seemingly demonstrating
that the rate-limiting step of this enzyme is rather the identifica-
tion of its substrate than the excision step itself. Additionally, this
study also revealed which residues are critical for the selectivity
and specificity of MutY.
Substrate release. The product release rate of MutY could be
greatly enhanced by the two proteins AP-endonuclease IV and
exonuclease III, and this effect depended on the presence of the
C-terminal domain of MutY (Pope et al., 2002). Also, endonu-
clease VIII was found to promote MutY dissociation from AP:G
substrates, but not from AP:8-oxo-G, and to further process these
by βδ elimination (Lu et al., 2006b). This study also showed that
MutY interacts with endo VIII through its C-terminus and com-
petes with endo VIII on its natural substrate, the hydroxyurea
(hoU):Amismatch, thus inhibiting its activity and possibly reduc-
ing the mutagenic effects of hoU. Taken together, it seems impor-
tant that also the substrate release step is tightly regulated, in
order to orchestrate the following steps and to protect the 1-nt
gap resulting from base-excision.
Structure of MutY and the removal of adenine opposite 8-oxo-G
The most precise structure of MutY comes from studies with
Bacillus stearothemophilus (Lee and Verdine, 2009) (Figure 2).
After binding to the 8-oxo-G:A mispair MutY flips out the A from
the DNA double-helix. A water molecule is positioned between
Asp144 and Asn146 in the MutY lesion-recognition pocket of
the enzyme. Earlier studies included biochemical and compu-
tational studies on uracil DNA glycosylase (Werner and Stivers,
2000; Dinner et al., 2001) suggested that a so called dissociative
action occurs, where the cleavage of the N-glycosylic bond and
the subsequent attack of the water molecule on the C1′ (arrow
in Figure 2A) do not occur simultaneously, but rather in two
FIGURE 2 | Adenine removal by MUTYH. (A) View of the substrate adenosine interacting with catalytic residues of MUTYH. (B) Proposed glycolytic
mechanism based on the structural information of (A). Reproduced form Lee and Verdine (2009). For details see text.
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discrete steps. In addition Glu43 can adopt a so-called bifur-
cated hydrogen-bonding interaction of 2.7 and 2.8 Angströms,
respectively, with N7 of A (Figures 2A,B). These short distances
together with a protonated Glu43, provides acidity and therefore
full hydrogen bonding to the N7 of A. As indicated in Figure 2B
such a conformation favors the scission of the glycosylic bond
between A and the deoxyribose. A similar structure has also been
identified for human MUTYH, for which a fragment lacking the
first 64 amino-acids was crystalized (Luncsford et al., 2010).
The structure of MutY catalytic core revealed that the two heli-
cal domains form a positively-charged groove, positioning the
A-binding pocket at their interface (Guan et al., 1998). Also, this
study confirmed a nucleotide flipping mechanism by a substi-
tution of the Watson–Crick hydrogen bond partners by protein
atoms. Recognition of 8-oxo-G seems to occur independently
of double-stranded DNA or of an A-mismatch, and sequential
extrusion of 8-oxo-G followed by A occurs in MutY, as demon-
strated by Bernards et al. (2002). MutY has been proposed to
assemble into a dimer upon substrate binding to yield an active
form of the enzyme (Wong et al., 2003). This idea was further
substantiated by a study that suggested a model for MutY binding
of the mismatched DNA that involves scanning of the DNA by
one molecule which enhances binding of second MutY molecule
upon encountering an A:8-oxo-G mismatch (Lee et al., 2004).
Kinetically, it has been suggested that the release of A happens
fast, while the rate-limiting step was the release of the AP-site
(McCann and Berti, 2003). Further investigations into the transi-
tion state structure of MutY showed that the irreversible breakage
of the N-glycosidic bond could not take place until a H2O atom
was present and that the enzyme stabilized the excision site after
excision (McCann and Berti, 2008). Recently, a two-step reaction
was proposed to be the basis of the catalytic activity of MutY, as
opposed to the three-step mechanism proposed before (Tiwari
et al., 2011).
Investigations of the roles of the different H2O molecules
involved in catalysis by MutY from B. stearothermophilus and
E. coli suggested that E43 andN7may be important factors for the
activity of MutY (Brunk et al., 2012). Further insight into the roles
of the substrate A residues N7 and N3 during catalytic excision by
MutY have been gained recently (Michelson et al., 2012).
MutY in living cells
In E. coli, MutY was shown to be co-transcribed as first gene of
a part of a large operon, together with Fpg, the bacterial DNA
glycosylase which removes 8-oxo-G from the DNA (Gifford and
Wallace, 1999). This further emphasized the involvement ofMutY
in the repair of 8-oxo-G base pairs in an interplay with Fpg
and thus in the response to oxidative DNA damage. Somewhat
surprisingly at first glance, oxidative stress down-regulated the
activity of MutY by 70% as well as its mRNA levels, and in con-
trary it was inducedmore than 2-fold under anaerobic conditions
(Yoon et al., 2003). This negative regulation of MutY was medi-
ated by the regulatory genes fur, fnr and arcA. These results were
explained with the idea that MutY activity had to be restrained
when increased incorporation of 8-oxo-dGTP could possibly take
place, which is during times of oxidative stress. This is impor-
tant, because 8-oxo-dGTP could be inserted opposite a correct
templating A, which might erroneously get excised by the action
ofMutY, thus actually acting promutagenic in this scenario instead
of protecting from mutations taking place.
Screening for mutator loci leading to GC→CG transversions
in E. coli, Zhang et al. found that inactivation of MutY led to accu-
mulation of these mutations (Zhang et al., 1998). As mentioned
above, they showed that MutY bound to G:8-oxo-G mismatches
and was capable of removing G from the G:8-oxo-G mispair.
To analyze the impact of mutT, mutM (which encodes the
Fpg DNA glycosylase that removes 8-oxo-G from C:8-oxo-G base
pairs in bacteria), andmutY on the mutational spectra, following
considerations have to be taken into account. In the context of 8-
oxo-G and 8-oxo-dGTP (1) CG→AT mutations can arise either
from oxidation of C:G to C:8-oxo-G or from incorporation of
8-oxo-dGTP opposite C, followed by wrong incorporation of A
opposite 8-oxo-G by the replicative pols during the next round of
replication. (2) AT→CGmutations are based on incorporation of
8-oxo-dGTP opposite templating A. Analyzing different combi-
nations of mutated strains inmutT, mutY, andmutM, Fowler et al.
found that (1) mutT does not increase CG→AT transversions,
regardless of themutY andmutM background, suggesting that 8-
oxo-dGTP does not often get incorporated opposite C but rather
opposite A. (2) AT→CG transversions are reduced in mutY and
mutMmutY backgrounds, suggesting templating 8-oxo-G prefer-
entially pairs with dATP, which then is a substrate for MutY to
excise A from the A:8-oxo-G pair, followed by Fpg that removes
8-oxo-G paired with C. And finally (3) mutY and mutMmutY
decrease AT→CG mutations (arising from incorporation of 8-
oxo-dGTP opposite templating A) in a mutT wt background,
suggesting that a certain amount of 8-oxo-G gets incorporated
into DNA even in the presence of functional MutT (Fowler et al.,
2003). No strand bias in the mutation rate between leading and
lagging strand synthesis in either a mutMmutY or a mutT back-
ground could be detected in E. coli using a supF shuttle vector
(Watanabe et al., 2001). Interestingly, Bridges et al. showed that
the rate of mutation markedly increased in starved mutY mutant
E. coli, yielding CG→AT transversion mutations (Bridges et al.,
1996). This phenotype could be further enhanced by additional
mutation ofmutM, even though mutation ofmutM alone did not
cause this effect. Also, addition of catalase to the plates did not
alter the mutation rates, indicating that extracellular H2O2 was
not involved in the generation of mutations, and it was suggested
that singlet oxygen could be the source of internal DNA damage.
These findings indicated that MutY may regulate the activity of
Fpg in resting cells. Expression of MutY from a mutY-lacZ fusion
construct was shown to be enhanced under aerobic compared
to anaerobic conditions, but not to be down-regulated by nutri-
ent limitation (Notley-McRobb et al., 2002). However, in many
cases, nutrient limitation led to mutY inactivation by deletion,
suggesting it might serve as a mechanism to increase mutation
rates under these adverse conditions.
Clustered lesions, as induced by ionizing radiation, are defined
as two or more lesions formed within one to two helical turns
of the DNA. They present a challenge to the repair machinery
of the cell. An 8-oxo-G in the vicinity of an AP site was found
to retard the processing of the AP site by endo III and Fpg,
and the AP site was found to elevate the mutation frequency at
Frontiers in Genetics | Cancer Genetics February 2013 | Volume 4 | Article 18 | 8
Introduction                                                       Regulation of the Human MutYH DNA Glycosylase by Ubiquitination
29
Markkanen et al. The genome cleaner MUTYH glycosylase
8-oxo-G in wt, nth, fpg, and mutY deleted E. coli (Cunniffe et al.,
2007). Interestingly though, the mutation frequency in mutYfpg
null cells was reduced by the presence of the AP site, suggest-
ing that the processing of tandem lesions challenges the cellular
repair machineries. Similar findings by Noguchi et al. investigat-
ing the interplay of 1-nt-gaps and 8-oxo-G lesions in clusters in
E. coli demonstrated again, that the mutagenic potential of 8-oxo-
G depends on the presence and the position of the gap (Noguchi
et al., 2012).
MutY competed with MutS-dependent mismatch-repair when
A:C mispairs were present, especially in the presence of an
increased dCTP pool (Kim et al., 2003). In E. coli, MutY has been
shown to interact via its Fe-S cluster with the ATPase domain of
MutS, which enhanced the binding affinity of MutY to A:8-oxo-
G mismatches (Bai and Lu, 2007). MutY expression and activity
were enhanced in a mutS mutant strain, and AT→GC transver-
sions were reduced by additional mutation of mutY in a mutS
background, suggesting a cooperative effect of MutY and MutS
in repair of 8-oxo-G damage. Analysis of Bacillus subtilis revealed
that the expression of MutY increased drastically upon deletion
of mutSL operon in starved cells, possibly to disturb the balance
between MutY and MMR proteins to support the production
of mutations, which might give growth advantages to these cells
(Debora et al., 2011).
In Streptococcus mutans, an oral pathogen, strains with muta-
tions of mutY were shown to display elevated mutation rates,
increased resistance to killing by acid and oxidative agents as well
as higher virulence compared to the parent strain, suggesting that
loss of a BER factor such as MutY could confer an advantage to
pathogenic organisms (Gonzalez et al., 2012).
MutY and BER in E. coli
Reconstitution experiments with purified proteins from E. coli
revealed, that the presence of Ape1, pol I, and DNA ligase is suf-
ficient to catalyze the entire repair pathway of G:A mismatches
in vitro (Au et al., 1989). Further elucidation of the pathway was
achieved, when Radicella et al. showed that the average repair
tract length initiated by MutY in E. coli is 9–27 nucleotides long,
starting at the removed A, and involved pol I, even though the
involvement of other pols was also evident (Radicella et al., 1993).
This finding was further refined in vitro, when Tsai-Wu et al.
found pol I to be responsible for generating these tracts of 5–12
nucleotides length (Tsai-Wu and Lu, 1994).
MUTYH
MUTYH activity and substrate specificity
The substrate specificities for MUTYH are summarized in
Table 1. The mammalian homolog of MutY, MUTYH, was first
purified from calf thymus and catalyzed removal of A from
A:G, A:8-oxo-G and A:C mismatches (McGoldrick et al., 1995).
Subsequently, expression and purification of the cloned human
protein confirmed its activity to remove A from A:8-oxo-G and
A:G base pairs in vitro, supporting that also the human homolog
is a bona fide DNA glycosylase (Slupska et al., 1999). Purification
of MUTYH from calf liver mitochondria yielded a protein that
complexes with A:8-oxo-G, G:8-oxo-G, and T:8-oxo-G, weakly
with C:8-oxo-G but not with A:G and A:C mismatches and
removed A mispaired with G, C, or 8-oxo-G while weakly remov-
ing G from G:8-oxo-G mispairs (Parker et al., 2000). Purification
of the murine MUTYH revealed strong similarities to MutY
function, even though the intrinsic rates of A removal were
lower than by MutY (Pope and David, 2005). Shinmura and
colleagues reported that both the purified nuclear and mitochon-
drial recombinant isoforms of human MUTYH were active, and
predominantly removed A from A:8-oxo-G mispairs rather than
A:G mispairs under physiological salt concentrations (Shinmura
et al., 2000). MUTYH in human cell extracts was shown to be
more active in binding and glycosylase activity toward A:G mis-
matches than recombinant MUTYH expressed in bacteria (Gu
and Lu, 2001). Furthermore, the authors found this native form
of MUTYH to migrate slower on a non-denaturing polyacry-
lamide gel than recombinant human MUTYH purified from
bacteria. Moreover the native form seems to be phosphorylated,
thus apparently enhancing its glycosylase activity predominantly
on A:G but also on A:8-oxo-G. As the phosphorylation status
of MUTYH did not alter its electric mobility, it was suggested
to be possibly associated with other proteins to account for the
higher apparent molecular weight. Accordingly, co-migration of
APE1 and MUTYH with A:8-oxo-G substrates could be identi-
fied. Ohtsubo et al. found that MUTYH likely also harbors an
activity to remove 2-OH-A (Ohtsubo et al., 2000). Removal of
2-OH-A from opposite 8-oxo-G or G has been described for
murine MUTYH (Pope and David, 2005) and was confirmed for
human MUTYH as well (Ushijima et al., 2005). MUTYH from
S. pombe was able to remove G from G:8-oxo-G mismatches as
efficiently as A from A:8-oxo-G mismatches, and its expression
reduced the frequency of GC→CG transversions in an E. coli
mutY mutant, suggesting it might be involved in the repair of
G:8-oxo-G lesions (Doi et al., 2005).
A:8-oxo-G substrates processed by murine MUTYH were
protected from inappropriate access by OGG1 and APE1, thus
preventing the formation of DSBs (Tominaga et al., 2004).
A study by Miyako et al. found that mitochondrial DNA
(mtDNA) fromHeLa cells could be cleaved by recombinant E. coli
MutY, in contrast to Fpg which has been shown to barely cleave
mtDNA (Driggers et al., 1993; Hegler et al., 1993), and that this
cleavage took place roughly at a rate that was expected to corre-
spond to the amount of 8-oxo-G present in endogenous mtDNA
(Miyako et al., 2000). Suzuki et al investigated the repair of
8-oxo-G in DNA and 8-oxo-dGTP in 293T cells using supF shut-
tle plasmids (Suzuki et al., 2010). While knockdown of OGG1,
MUTYH, NTH1, and NEIL1 all led to a significant increase in
CG→AT transversions caused by the C:8-oxo-G pair in the shut-
tle plasmid, only knockdown of MUTYH resulted in a reduction
in AT→CG transversions induced by 8-oxo-dGTP. In summary,
MUTYH displays remarkable similarity to its bacterial homolog
MutY regarding its activity and substrate specificity.
Localization of MUTYH
The subcellular localization of MUTYH was rather enigmatic for
a long time. A study using expression of tagged proteins in COS-7
cells revealed that MUTYH was mainly transported to the mito-
chondria, which was probably the result of the isoform that was
used (Takao et al., 1998). Follow-up work by the same group
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identified an alternatively spliced transcript differing in exon 1,
leading to the nuclear localization of this variant (Takao et al.,
1999). Ten further isoforms containing unique 5�sequences that
could be grouped into three types were subsequently described,
and suggested to encode multiple authentic MUTYH proteins
(Ohtsubo et al., 2000). Other reports have further discussed the
localization of MUTYH in cells, finding isoforms targeted to the
nucleus (Tsai-Wu et al., 2000; Ichinoe et al., 2004) or the mito-
chondria (Englander et al., 2002; Ichinoe et al., 2004). However,
work still needs to be done to analyze the distribution of iso-
forms to the different subcellular compartments in different cell
and tissue types to clarify this matter further.
Analyzing the distribution of endogenous MUTYH in serum-
stimulated proliferating MRC5 cells with antibodies, Boldogh
et al. reported both nuclear and mitochondrial localization of
MUTYH (Boldogh et al., 2001). The nuclear form co-localized
with BrdU and the proliferating cell nuclear antigen (PCNA)
and, similarly to PCNA, increased 3- to 4-fold to peak during S-
phase compared to G1, whereas levels of OGG1 or MTH1 did not
change during the cell cycle. These studies suggested a role of tar-
geting MUTYH to the replication fork to ensure that its activity is
directed to the newly synthesized template strand. Subsequently,
DNA replication was shown to enhance the MUTYH-dependent
repair of A:8-oxo-G mismatches in vivo, and it was demonstrated
that the interaction with PCNA was critical for the activity of
MUTYH (Hayashi et al., 2002). Taken together, these findings
clearly support a replication-associated function of MUTYH.
MUTYH and DNA damage signaling
Recently, a number of reports have accumulated that link
MUTYH to the DNA damage response and implicate it in apop-
totic signaling. To investigate the contribution of nuclear and
mitochondrial accumulation of oxidative base lesions to the trig-
gering of apoptosis, Oka and colleagues used OGG1 knockout
(ko) cells deficient in the nuclear or mitochondrial form of
MUTYH, respectively (Oka et al., 2008). The accumulation of
single-strand breaks in nuclear DNA triggered PARP-dependent
cell death and could be rescued by depletion of nuclear MUTYH.
The same was true for mitochondria, where MUTYH trig-
gered calpain-dependent cell death by single-strand breaks. These
results suggested that MUTYH catalyzes the formation of single-
strand breaks in both of these DNAs, hence leading to the execu-
tion of apoptosis. Exposure of human cells to sodium nitroprus-
side, an agent that causes 8-oxo-G accumulation in cellular DNA
by acting as an NO donor, led to MUTYH-dependent cell death
that was initiated by oxidized bases in the mitochondrial, but not
the nuclear DNA (Ichikawa et al., 2008). The role of single-strand
breaks generated by MUTYH in the induction of cell death was
further underlined by the finding that synthetic sickness/lethality
mediated by either inhibition of pol β combined with MSH2, a
component of the mismatch repair pathway, or pol γ with MLH1,
both of which led to a nuclear 8-oxo-G accumulation, could be
rescued by silencing of MUTYH (Martin et al., 2010). BER has
been implicated in many different pathological conditions of the
central nervous system (reviewed in Bosshard et al., 2012). A
very recent report implicated MUTYH in degeneration by trig-
gering apoptosis in microglia and neurons through initiation
of single-strand breaks during repair of A:8-oxo-G mismatches
(Sheng et al., 2012). Nuclear accumulation of 8-oxo-G triggered
PARP-dependent apoptosis in microglia, while mitochondrial 8-
oxo-G accumulation led to calpain-dependent apoptosis in neu-
rons. All these findings are in agreement with a model, wherein
the repair of DNAmismatches by MUTYH leads to generation of
toxic single-strand breaks, and thus contributes to cellular death
in case of excessive damage burden (i.e., an amount of DNA dam-
age that surpasses the cellular capacity to further process these
lesions properly). Thus, this model explains, why under condi-
tions of severe damage the absence of MUTYH is beneficial for the
survival of the cells. On the other hand, there are a number of
reports that show that loss of MUTYH actually can sensitize cells
to DNA damaging agents. Along this line, double mutations in
S. pombe MUTYH with RAD1 or, to a lesser extent RAD9, were
shown to enhance the sensitivity of the cells to DNA damaging
agents and hydroxyurea (Jansson et al., 2008). The consequences
of these deficiencies were chromosome segregation defects and
checkpoint failure after UV irradiation, as well as morphologi-
cal defects, even in the absence of DNA damaging agents. This
implicated MUTYH in the repair of a wide range of DNA damage
and linked it to the checkpoint pathway. Under low-dose oxida-
tive stress, MUTYH OGG1 double-ko mouse cells also showed
hypersensitivity to oxidation damage and a reduction of S phase
concomitant with an increase of G2/M phase cells, while the levels
of cell death remained unchanged (Xie et al., 2008). Furthermore,
an increase in centrosome amplifications and formation of mult-
inucleated cells could be observed in the surviving fraction of
the ko cells, suggesting an involvement of MUTYH and OGG1
in the regulation of cell-cycle progression and cell division under
oxidative stress. Further evidence implicating MUTYH in check-
point control came from a study showing that siRNA-mediated
knockdown of MUTYH resulted in a decreased phosphorylation
of ATR and Chk1 upon treatment of HEK293 cells with HU or
UV (Hahm et al., 2011). Concomitantly, the authors observed an
increase in the phosphorylation of Cdk2 as well as the amount of
the Cdc25A phosphatase, suggesting that MUTYH was involved
in activation of the DNA damage response.
Thus, there seems to be growing evidence that implicates
MUTYH to be an important factor in the cellular response to
oxidative stress and inflammatory conditions by an involvement
in cell death signaling (as discussed in Oka and Nakabeppu,
2011). Along these lines, MUTYH has been suggested to play
a role in mitochondrial dysfunction in the pathogenesis of
Parkinson’s disease (Fukae et al., 2007; Nakabeppu et al., 2007).
However, it still remains to be clarified how MUTYH can initiate
apoptosis of cells in some instances, while it seems to protect from
apoptosis in others.
Impact of MUTYH knockout on oxidative DNA damage and
tumorigenesis in vivo
The data on cells and mice with biallelic deletion of MUTYH are
somewhat discrepant.MUTYHko embryonic stem cells displayed
a mutator phenotype, but did not show any hypersensitivity
toward oxidative stress induced by H2O2 or menadione (Hirano
et al., 2003). A study with mutyh−/− knockout mice by Xie et al
revealed no significant increase in survival or tumor incidence
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after 14 months, suggesting that MUTYH deficiency is not suf-
ficient to cause a tumor-predisposition (Xie et al., 2004). This
study also showed that combined ko of MUTYH with OGG1
led to a decrease in life span and increased tumor formation for
double ko mice compared to single ko. Interestingly, 75% of the
lung tumors showed an activating GC→TA transversion muta-
tion at codon 12 of K-ras, a feature that is often detected in
MUTYH-associated polyposis (MAP) tumors, but none in the
p53 gene or in the adjacent normal tissues. Additional heterozy-
gosity forMsh2 (mutyh−/− ogg1−/− msh2±) did not inflict on the
total tumor incidence but accelerated malignant lung and ovarian
tumor formation in the mutyh−/− ogg1−/− background. A com-
plete knockout of Msh2 to generate triple ko (mutyh−/− ogg1−/−
msh2−/−) further increased tumor incidence and decreased sur-
vival time, but did not differ from the phenotype displayed by
msh2−/− single knockouts. This was suggested to be due to the
strong mutator phenotype of msh2−/− mice that might mask
additional difference caused bymutyh−/− and ogg1−/−.
Spontaneous mutagenesis in the small intestine of ogg1−/−
and mutyh−/− ogg1−/− double deficient mice at the age of
4–5 weeks using a transgene reporter revealed increased muta-
tions in the double-ko’s but not in the ogg1−/− mice (Isogawa,
2004). Furthermore, the GC→TA mutation frequency increased
in mutyh−/− and in ogg1−/−and a cooperative increase could be
observed in mutyh−/− ogg1−/−, suggesting a cooperative func-
tion between OGG1 and MUTYH to prevent 8-oxoG-related
mutagenesis. Russo et al. also reported an additive effect in
mutyh−/− ogg1−/− on the age-dependent increase in 8-oxo-G
levels in lung and small intestine compared to the single ko’s
(Russo et al., 2004). Strikingly, these tissues were identical with
the ones that showed increased cancer incidence in mutyh−/−
ogg1−/−mice in the study by Xie et al. (2004). MUTYHdeficiency
in a background of APCmin/+ mice led to the occurrence of stop-
codons in the APC gene by induction of CG→AT transversion
mutations and thus promoted intestinal tumorigenesis (Sieber
et al., 2004).
In 2007 a study reported an increased susceptibility to spon-
taneous and stress-induced tumorigenesis in a large cohort of
mutyh−/− mice kept for 18 months, strongly contradicting data
on mutyh−/− obtained by different groups thus far (Sakamoto
et al., 2007). This suggested that presence of a MUTYH deficiency
is sufficient to predispose for malignancies of the intestinal tract,
such as lymphoma and adenoma. More impressively still, oral
KBrO3 treatment of mutyh−/− mice led to a dramatic increase
in CG→AT transversion mutations and small intestinal tumors.
The authors claimed that the tumor-prone phenotype might have
been missed earlier due to genetic differences in the mouse strains
and the older age at which the tumor burden was evaluated in
their study. This was in line with the fact that many of the stud-
ies with mutyh−/− mice have been reporting a strong tendency
toward age-dependent accumulation of 8-oxo-G in tissues. In
general, in light of the huge complexity of the disease, it can
be debated, whether mice are useful cancer models to compare
with the human disease, due to the entirely different life span,
metabolism, inbreeding status and many other aspects.
As noted above, the combination mutyh−/− and msh2−/−
did not greatly affect the mutation rate. However, the loss of
mutyh−/− combined with msh2−/− significantly increased the
amount of oxidative DNA damage in several organs compared to
msh2−/− mice, suggesting an independent contribution of both
genes to genetic maintenance (Russo et al., 2009). Surprisingly,
the development of metastasizing lymphoma and the time of
death were significantly delayed in the mutyh−/−msh2−/− mice
compared to msh2−/−, suggesting that the cancer-prone pheno-
type of the double knockouts depends substantially on the activity
of MUTYH (Russo et al., 2009). The relationship of MUTYH and
MMR is reviewed in more detail in Russo et al. (2007).
In a mouse model of ulcerative colitis MUTYH was shown to
play a major role in propagating the inflammatory response that
lead to the onset of chronic colitis (Casorelli et al., 2010). Taken
together, all the data analyzing the function of MUTYH in vivo
strongly supports the idea that MUTYH-mediated correction
of A:8-oxo-G mispairs plays an important role in the main-
tenance of genetic integrity and protects cells from malignant
transformation.
THE MUTYH/POL λ BASE-EXCISION REPAIR PATHWAY
By catalyzing the excision of the mispaired A from A:8-oxo-G
base pairs, MUTYH paves the way for a subsequent repair that
ultimately reconstitutes an undamaged C:G base pair. MUTYH-
initiated repair has been shown to involve a replication-coupled
long-patch BER (LP-BER) pathway (Matsumoto, 2001; Parker
et al., 2001; Yang et al., 2001; Parlanti et al., 2002). Along this
line, a SP-BER pathway initiated by MUTYH was shown to be
futile, because it uniquely generated A:8-oxo-G base pairs instead
of the correct C:8-oxo-G base pairs, indicating that canonical
MUTYH-initiated BERmust proceed by the LP-BER sub-pathway
(Hashimoto et al., 2004). For a long time it was unclear, which
pol was capable of faithfully inserting a correct C opposite 8-oxo-
G, as most examined pols showed significant error-prone bypass
of 8-oxo-G (Shibutani et al., 1991; Pinz et al., 1995; Efrati et al.,
1999; Prakash et al., 2000; Einolf and Guengerich, 2001; Vaisman
and Woodgate, 2001; Krahn et al., 2003; Hsu et al., 2004). In
2007, our laboratory proposed that pol λ, together with its cofac-
tors PCNA and replication protein A (RPA), inserts 1200-fold
more efficiently the correct C opposite 8-oxo-G than the incorrect
A (Maga et al., 2007). Furthermore, experiments with extracts
from mouse embryonic fibroblasts (MEFs) deficient for pol λ
suggested an important role of pol λ in bypass of 8-oxo-G. The
importance of PCNA and RPA to determine the pol selection at
8-oxo-G lesions was further analyzed in a follow-up study. The
two proteins were found to act as molecular switches to acti-
vate pol λ-dependent correct 8-oxo-G bypass and to repress the
more error-prone pol β-dependent bypass (Maga et al., 2008).
Subsequently, we showed that the MUTYH-initiated error-free
LP-BER pathway involves pol λ (Maga et al., 2008; Van Loon
and Hubscher, 2009), as depicted in detail in Figure 1. Herein,
the monofunctional MUTYH excises the promutagenic A from
A:8-oxo-G base pairs. This is followed by incision of the phospho-
diester backbone 5� to the AP site by APE 1 that generates a 3�OH
and a 5�dRP moiety, respectively. Thereafter, in the presence of
RPA and PCNA, pol λ incorporates the correct C opposite 8-oxo-
G and further elongates the primer by one more nucleotide (nt)
downstream, thus generating a short 1-nt 5� flap. This overhang
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is processed by flap endonuclease 1 (Fen1), resulting in a product
that can be ligated by DNA ligase I. The resulting C:8-oxo-G base
pair is then substrate for the canonical OGG1-initiated SP-BER as
discussed above.
MUTYH-INTERACTING PROTEINS
All DNAdamage repair pathways have to be tightly coordinated to
ensure proper repair and to avoid the generation of cytotoxic and
mutagenic intermediates. Protein-protein interactions either reg-
ulate the repair by recruitment of proteins to sites of DNAdamage
or modulate the catalytic activity of already bound enzymes.
MUTYH is interacting with proteins associated with the BER
pathway, DNA replication and cell cycle checkpoints (Table 2).
The first interaction partner of MUTYH was the endonuclease
Ape1 (Parker et al., 2001; Yang et al., 2001). Ape1 stimulates the
glycosylase activity of MUTYH independently from its own activ-
ity; a catalytically dead mutant of Ape1 still enhanced the cleavage
efficiency of MUTYH on damaged DNA templates (Yang et al.,
2001). Thus, the stabilization of the MUTYH-DNA complex was
sufficient to enhance the repair capacity. Additionally, MUTYH
and Ape1 were both recruited into a complex with A:8-oxo-G
containing DNA in HeLa cell extracts (Gu and Lu, 2001). The
interaction between the two proteins was suggested to be impor-
tant to prevent the release of cytotoxic AP sites (Luncsford et al.,
2010). MUTYH was found to interact with pol λ, as discussed
above (Van Loon andHubscher, 2009). Furthermore, the interac-
tion of MUTYH with pol λ was enhanced by phosphorylation of
pol λ by Cdk2/cyclinA (Markkanen et al., 2012b,c).
Gu et al identified the mismatch repair protein MSH6 as
further interaction partner of MUTYH, and MSH6 regulated
MUTYHby stimulating its glycosylase activity and binding capac-
ity to A:8-oxo-G containing DNA (Gu et al., 2002).
MUTYH interacts with PCNA and RPA under conditions
of unperturbed DNA replication. It was suggested that, upon
encountering DNA damage, MUTYH switches to interact with
the heterotrimeric ring-like molecule Rad 9, Rad1, and Hus 1,
called the 9-1-1 complex (Parker et al., 2001; Shi et al., 2006).
Consistent with these findings, MUTYH co-localized with PCNA
at replication foci in untreated cells (Boldogh et al., 2001). Also,
replication was a prerequisite for MUTYH mediated repair to
occur (Hayashi et al., 2002). The interaction site with PCNA was
mapped to a conserved region within the MutY family, reflecting
the importance of this interaction since PCNA directs MUTYH to
the daughter strand where it excises a recently inserted mispaired
A from A:8-oxo-G base pairs (Slupska et al., 1999). This direc-
tionality could also be the mechanism to make sure that MUTYH
does not excise erroneously A from a base pair where 8-oxo-dGTP
has been inserted opposite a templating (and thus correct) A. The
interaction ofMUTYHwith PCNA and the structurally-related 9-
1-1 complex was also confirmed in S. pombe (Parker et al., 2001;
Chang and Lu, 2002, 2005; Shi et al., 2006; Luncsford et al., 2010).
Interestingly, it was shown that even if the SpMUTYH does not
have a perfect PCNA binding motif (Chang and Lu, 2005), cross-
binding between the yeast and the human isoforms is possible and
mutations within the PCNA binding domain impair the capabil-
ity of MUTYH to repair A:8-oxo-G mismatches in yeast (Chang
and Lu, 2002).
The 9-1-1 complex acts as a DNA damage sensor, blocks the
cell cycle and simultaneously stimulates BER to allow repair to
be completed before the DNA is replicated. The human MUTYH
interacts with the h9-1-1 complex via binding to hRad1 and
hHus1, but not to hRad9 (Shi et al., 2006). The glycosylase activ-
ity of MUTYH was stimulated by this interaction if 9-1-1 was
present in a substantial molar excess. Treatment of cells with
H2O2 or ionizing irradiation enhanced this interaction, support-
ing the hypothesis that 9-1-1 replaces PCNA in stress situations
(Shi et al., 2006). Luncsford et al. identified the interdomain con-
nector (IDC) of MUTYH to mediate the binding to 9-1-1 by
providing a stabilized docking interface and proved the impor-
tance of the interaction by showing that mutations within this site
decrease the repair of oxidative damage in vivo (Luncsford et al.,
2010).
Partial interchangeability was observed between human and
S. pombe homologs of these proteins, and enhanced glycosylase
Table 2 | Interaction partners of MUTYH.
Interaction partner Species Interaction site in MUTYH Stimulatory effect
Ape1 human 259–318 (Parker et al., 2001) Glycosylase activity (Yang et al., 2001)
MSH6 human 232–254 (Gu et al., 2002) Glycosylase activity DNA binding (Gu et al., 2002)
Pol λ human Van Loon and Hubscher, 2009; Markkanen et al., 2012c
40–130 (Dorn et al., unpublished results)
n.d.
PCNA human 505–527 (Parker et al., 2001), F518/F519 (Chang and Lu, 2002) n.d.
S. pombe 438–445 (Chang and Lu, 2002) n.d.
9-1-1 human 295–350 (Shi et al., 2006)
V315, E316 (Shi et al., 2006; Luncsford et al., 2010)
Glycosylase activity (Chang and Lu, 2005),
interaction increased after IR (Shi et al., 2006)
S. pombe 245–293 (Chang and Lu, 2005)
I261, E262
Glycosylase activity (Chang and Lu, 2005),
interaction increased after H2O2 treatment
RPA human 6–32 (Parker et al., 2001) n.d.
ATR human n.d. Checkpoint mediator? (Hahm et al., 2011)
n.d., not determined.
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activity of S. pombe MUTYH was found with human Hus1
and the S. pombe 9-1-1. Human MUTYH was also observed
to co-localize with Rad9 in cells treated with H2O2, suggest-
ing that BER by MUTYH could be modulated by 9-1-1. Further
work in S. pombe showed a decrease in repair of oxidative DNA
damage in vivo when the interaction of MUTYH with 9-1-1
was disrupted, suggesting that this interplay significantly con-
tributes to the response to oxidative stress (Luncsford et al., 2010).
Also, MUTYH could be co-immunoprecipitated with ATR from
human cells, possibly implicating MUTYH in ATR-mediated
checkpoint execution (Hahm et al., 2011).
MUTYH from S. pombe was found to interact with Hst4, a
histone deacetylase involved in silencing of genes and mainte-
nance of genomic integrity, which seemed to regulate the levels of
Hst4 after oxidative stress (Chang et al., 2011). Hst4 was further
shown to interact also with the 9-1-1 complex. The association of
MUTYH with telomeres was increased after oxidative stress and
by deletion of Hst4, and Hst4 bound to telomeres decreased after
oxidative stress, concomitant with a decrease in total Hst4 levels.
Finally, MUTYH association with telomeres was increased in a
Hst4 deletion background in the presence of chronic DNA dam-
age caused by the lack of Hst4. Therefore, MUTYH seemed to reg-
ulate repair of telomeres by orchestrating the functions of 9-1-1
and Hst4. Finally, the WRN helicase/exonuclease was recently
shown to promote MUTYH-initiated LP-BER of A:8-oxo-G mis-
matches by pol λ (Kanagaraj et al., 2012).
REGULATION OF MUTYH
REGULATION OF MUTYH LEVELS
So far, only a limited amount of studies has been performed con-
cerning the regulation of MUTYH levels. Respiratory hypoxia
caused a strong increase in mtDNA damage and also in expres-
sion of MUTYHmRNA in rat brain (Englander et al., 2002). This
suggested that the increase denoted an adaptive mechanism for
protection of neuronal DNA from oxidative injuries stemming
from an imbalance in metabolism. Follow-up work by the same
group identified specific MUTYH isoforms exclusive to brain tis-
sue in rats, that were targeted to the mitochondria and some of
them were inducible upon respiratory hypoxia (Englander et al.,
2002). The divergence in the N-terminus between the different
MUTYH isoforms was found to influence their excision rates
and the processing of AP sites (Ma et al., 2004). In mononu-
clear blood cells MUTYH levels were neither altered by hypoxia
nor by inhalation of 10% oxygen for 2 h and the subsequent
reoxygenation period in healthy human subjects, even though
DNA strand breaks and oxidatively damaged purines accumu-
lated by this treatment (Risom et al., 2007). MUTYH, together
with SMUG1, was regulated transcriptionally by p73, a member
of the p53 protein family, through DNA damage induction by
bile acid exposure, suggesting that this interplay regulates DNA
damage repair (Zaika et al., 2011).
A comparison of embryonic stem cells to more differenti-
ated cells did not reveal any impact on the mRNA levels of
MUTYH, in contrast to OGG1, which decreased upon differenti-
ation (Kuboyama et al., 2011). Alimentary supplementation with
quercetin, a plant-derived flavonoid that has been attributed with
anticarcinogen, was found to enhance the expression of MUTYH
in the distal colon mucosa of rats (Dihal et al., 2008). And finally,
overexpression of hepatitis B virus X (HBx) was shown to increase
8-oxo-G levels in HepG2 cells, and to decrease the transcript lev-
els of MUTYHα mRNA, while not affecting mRNA of OGG1,
suggesting that this may be linked to the development of hepa-
tocellular carcinoma which is associated to HBx infection (Cheng
et al., 2009).
REGULATION OF MUTYH BY POSTTRANSLATIONALMODIFICATIONS
Very little is known about the regulation of MUTYH by post-
translational modifications (PTM) (Table 3). Findings from Gu
et al. showed that MUTYH could be phosphorylated in vitro
by different protein kinases (Gu and Lu, 2001). Comparison of
the activity of native MUTYH from human cell extracts with in
recombinant MUTYH purified from bacteria revealed a dramatic
difference in the glycosylase activity, probably due to the phos-
phorylation state of the proteins. Indeed, the dephosphorylation
of native MUTYH led to a tremendous loss of function on A:G or
A:8-oxo-G mismatch containing templates. Differences in activ-
ity were also described for recombinant MUTYH expressed in
bacteria or insect cells (Kundu et al., 2010). Mass spectrometric
analysis confirmed S524 to be phosphorylated in the more active
MUTYH, expressed in insect cells. Further functional studies
usingwt, phosphomimetic, or phosphodeficientmutants revealed
an important role of S524 in substrate recognition and binding to
DNA.
A defect in phosphorylation of MUTYH was also found to
cause a mutator phenotype in different microsatellite stable col-
orectal cancer cell lines (Parker et al., 2002). All tested cell lines
that showed elevated 8-oxo-G levels showed a decline in repair
of A:8-oxo-G mismatches. While the sequencing of the MUTYH
locus in these cells did not reveal any mutations, the mRNA and
protein levels of MUTYH were decreased. In a subsequent study
the same authors could demonstrate that a loss of MUTYH phos-
phorylation by PKC was responsible for the observed increase
in 8-oxo-G causing the mutator phenotype (Parker et al., 2003).
The 8-oxo-G repair capacity in MUTYH impaired cell extracts
could be restored by complementation with PKC, PKA or casein
kinase II. Furthermore, the same effect could be achieved by treat-
ment with the PKC activator phorbol-12-myristate-13-acetate
(PMA). In contrast to that, no effect in cell extracts fromMUTYH
proficient cells occurred, indicating that MUTYH was already
Table 3 | Posttranslational modifications of MUTYH.
Posttranslational Site of Kinase Stimulatory
modification modification effect
Phosphorylation
(Gu and Lu, 2001)
n.d. n.d. Glycosylase activity
Phosphorylation
(Parker et al., 2002,
2003)
n.d. PKC
PKA
Casein Kinase II
Glycosylase activity
Phosphorylation
(Kundu et al., 2010)
S524 n.d. DNA-binding
n.d., not determined.
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phosphorylated at a basal level in these cell lines. Consistent
with these findings, MUTYH was a substrate for PKC in vitro.
Finally, MUTYH purified directly from cell extracts treated with
PMA showed an elevated capacity in the repair of A:8-oxo-G
mismatches. So far it has not been elucidated whether phospho-
rylation only interferes with the catalytic activity of MUTYH,
regulates its interaction with other proteins, or leads to a different
subcellular localization. Since PKC can be stimulated by oxidative
stress (Klein et al., 2000), it is possible that the phosphorylation-
mediated regulation of MUTYH presents an adaptive response to
DNA damage.
Taken together, it would be very interesting to investigate the
regulation of MUTYH in more detail to get a better understand-
ing how the different players of the 8-oxo-G repair machinery are
controlled to protect cells from oxidative stress of endogenous or
exogenous sources.
INVOLVEMENT OF MUTYH IN DISEASE
MAP (MUTYH ASSOCIATED POLYPOSIS)
Familial adenomatous polyposis (FAP) is an autosomal dominant
disease characterized by the formation of hundreds to thousands
of adenomatous polyps in the colons and rectums of the affected
patients (reviewed in Fearnhead et al., 2001). It is caused by
a germline mutation in the adenomatous polyposis coli (APC)
gene, mutations that are also responsible for 80% of the sporadic
colorectal tumors. In 2002, Al-Tassan and co-workers studied a
British family with multiple colorectal adenoma and carcinoma,
but failed to detect a mutation in the APC gene (Al-Tassan et al.,
2002). Closer analysis of the patientmaterial revealed an increased
tendency of somatic CG→AT transversion mutations in the APC
gene, which is consistent with 8-oxo-G mediated mutagenesis.
This observation led the authors to dissect the three enzymes
that work synergistically to counteract 8-oxo-G mediated muta-
genesis, namely OGG1, MUTYH, and MTH. Sequencing of the
respective genes revealed two non-conservative mutations in the
MUTYH gene, Y165C (through an A→G transition) and G382D
(through a G→A transition), while no pathogenic changes were
observed in the OGG1 andMTH genes. The two mutations were
found to reduce the activity of E. coli mutY to remove A from
G:A mismatches by 98% and 86%, respectively, suggesting that
a defect in MUTYH activity was the reason for the accumulated
mutations in the patients and thus responsible for the APC-like
phenotype. Subsequent work revealed that these mutations not
only compromise the bacterial mutY, but also caused a decrease in
the activity of human MUTYH for excision of A opposite 8-oxo-
G, which nicely correlated with the tumor phenotype (Al-Tassan
et al., 2002; Chmiel et al., 2003; Pope and David, 2005). Further
investigation led to the identification of seven other unrelated
patients with colorectal adenomas or carcinomas that showed a
bias of CG→AT transversion mutations to be carriers of biallelic
germline mutations for MUTYH (Jones et al., 2002). This disor-
der is the only colorectal cancer form inherited in an autosomal
recessive mode and is now commonly referred to asMAP, or infre-
quently also as FAP2 (http://www.omim.org). The prevalence of
MAP is estimated to be around 1% of all colorectal cancer cases
(Enholm et al., 2003; Croitoru et al., 2004; Fleischmann et al.,
2004; Wang et al., 2004; Peterlongo et al., 2005; Webb et al., 2006;
Kury et al., 2007; Cleary et al., 2009) andMUTYHmutations have
been found in 7% (Filipe et al., 2009), and 10% (Pezzi et al.,
2009) of FAP patients and 40% of AFAP patients, respectively
(Filipe et al., 2009). The lifetime-cancer risk is assessed to 80%
for colon cancer and 4% for duodenal cancer (Jasperson et al.,
2010). Even though MAP is a rather recently discovered disease,
many germline mutations in addition to the two found by Al-
Tassan et al have been described so far. This is reflected in the
abundance of literature investigating different single-nucleotide
polymorphisms and their relevance to cancer development has
been thoroughly reviewed in Cheadle and Sampson (2007) and
Poulsen and Bisgaard (2008). Interestingly, other than MUTYH,
no association of further genes involved in BER or the repair of
oxidative DNA damage with a multiple colorectal adenoma phe-
notype has been found so far (Dallosso et al., 2008). Interestingly
though, work by the Sweasy group has found that the POLB
gene is mutated in many colorectal cancers, suggesting that at
least some of these mutations may lead to compromised BER
function in the affected tissues (Donigan et al., 2012; Nemec
et al., 2012). MAP patients have been reported to be more prone
also to extraintestinal tumors such as ovarian, bladder, skin, and
breast cancer. For an overview of all extracolonic manifestations
of MAP-patients, please refer to this recent review (Nielsen et al.,
2011). For further clinical features, there are excellent recent
reviews available (Jasperson et al., 2010; Nielsen et al., 2011).
Several mutations in MUTYH associated with MAP were found
to significantly enhance the spontaneous mutator phenotype of
patient’s lymphoblasts under conditions of oxidative stress and
to accumulate 8-oxo-G in the DNA, underlining the role of
MUTYH in the pathogenesis of this disease (Ruggieri et al., 2012).
However, for many of the mutants it is unclear how the mutation
affects its activity, and more work is needed to clarify their exact
contribution to the disease.
EQUINE CEREBELLAR ABIOTROPHY
Interestingly, MUTYH has been suggested to be involved in the
pathogenesis of equine cerebellar abiotrophy, a neurological dis-
ease found in Arabian horses, as indicated by a SNP in the GATA2
binding region of the MUTYH promoter (Brault et al., 2011).
Whether there is a real causative role and what mechanisms are
behind it, remains to be elucidated by further studies.
CONCLUSIONS AND PERSPECTIVES
The MUTYH DNA glycosylase is a remarkable enzyme since it
has the specificity to remove an undamaged DNA base from a
mismatch such as an A:8-oxo-G. It is found throughout evolution
from bacteria to human, suggesting an essential role in prevent-
ing mutations arising from oxidative damage to the DNA. During
the last three decades, our knowledge about how MUTYH func-
tions has grown substantially. We now understand quite in detail
how MUTYH acts catalytically, and the structures of prokary-
otic and eukaryotic enzymes have been identified. However, the
functional details of the at least 10 isoforms of MUTYH, are
far from being unequivocally clarified. MUTYH acts together
with pol λ in the so-called MUTYH/pol λ pathway that can
replace a promutagenic A paired to an 8-oxo-G with a correct C.
The interaction with the moving platforms PCNA and the 9-1-1
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complex is apparently very important for the proper spatial and
temporal engagement of MUTYH on the DNA, and there espe-
cially in the context of chromatin. So far, very little is known about
the regulation of MUTYH, which is at least in part likely achieved
by PTM. Phosphorylation as an important PTM contributes to
regulate the activity of MUTYH. It is likely that other PTM’s, such
as ubiquitination, will be identified that govern the temporal (i.e.,
during the cell cycle) as well as the spatial (i.e., the subcellular
localization) distribution of MUTYH. Also, the fact that muta-
tions in MUTYH are identified in diseases of human and animals
shifts this enzyme more and more into the focus of translational
medicine. In the future, it will be of interest to understand more
about the subcellular localization and specific functions of the
different isoforms of MUTYH. Also, the exact regulation of the
activity, stability, and localization of this enzyme is likely to yield
many novel insights. Finally, we are anticipating further clarifica-
tion of the functional roles of the different mutations in MUTYH
associated with MAP.
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3.4.1. Recent developments according the MutYH glycosylase – an update since  
  02/2013
The polymorphic AluYb8 insertion in the 15th intron of the MutYH gene 
(AluYb8MutYH) was already known to increase the amount of 8-OH-dG lesions in the 
genomic DNA (80). In a follow up study Guo et al. could show that this variant leads 
to a significant reduction of the mitochondrial MutYH variant. AluYb8MutYH further 
affects the maintenance of mitochondrial DNA (mtDNA) and the functional mitochon-
drial mass in homozygous individuals (81). This result confirms an important role for 
MutYH in the repair of mtDNA. 
MutYH interacts with the Rad9-Rad1-Hus1 (9-1-1) complex as described before (82). 
A recent study investigated the role of MutYH in DNA damage repair in the context of 
9-1-1 depletion in yeast. Treatment of cells with cisplatin led to an overall accumula-
tion of MutYH while phleomycine treatment caused a more specific increase of MutYH 
on the chromatin. Jannson et al. observed a general re-localization of MutYH to the 
nucleus after exposure of cells to chemotherapeutics (83). 
A MutYH variant found in MAP patients, MutYH Q338H, was characterized by Turco et 
al. They found the glycosylase activity to be completely retained, but a reduced ability 
to bind the 9-1-1 complex. Cells expressing this mutant showed a hypersensitivity to 
oxidants and an accumulation in S-phase (84). Taken together these results show that 
a proper interaction between the S-phase checkpoint 9-1-1 and MutYH is needed to 
enable DNA damage repair.
Analysis of patients suffering from colorectal cancer elucidated that the 324His/His 
MutYH genotype is associated with a higher risk of cancer development. The authors 
could further correlate a decreased repair capacity of oxidative DNA damages with this 
MutYH mutation phenotype (85).
Consistent with this result another study identified a KRAS mutation in MAP patients. 
This mutation was not found in patients suffering from classical/attenuated familial 
polyposis adenomas. The c.34G>T transversion mutation in the KRAS gene is typically 
associated with oxidative DNA damage (86).
Ruggieri et al. analyzed lymphoblast cell lines derived from seven MAP patients, that 
carry different MutYH mutations. All of the tested cells were defective in removing A 
mispaired to 8-oxo-G and consequently showed elevated mutation rates.    
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The mutation frequency could even be enhanced by treatment with KBrO3 (72).
Taken together these recent results confirm again the important role of MutYH in the 
maintenance of genomic integrity and the consequences of any mis-regulation.
3.5. DNA polymerase λ
DNA Pol λ is, together with DNA Pol β, μ and TdT, a member of the Pol X family, which 
is known to be mainly involved in the repair of small gaps in the DNA (87). The protein 
is encoded on chromosome 10 and gives rise to a 575 kDa protein (88) that was shown 
to be expressed at the highest levels in testis, ovary and fetal liver (89,90).
The protein is structured in a BRCT domain (N-terminal-BRAC1 (breast-cancer-suscep-
tibility protein-1) C-terminal-domain), a serine-prolin-rich region and in the C-terminal 
catalytic core (Figure 6) (91). The catalytic core of DNA Pol λ shares 33% of identity with 
DNA Pol β and consists of the 8 kDa domain and the polymerase domain, including 
palm, fingers and thumb. The BRCT domain is suggested to mediate protein-protein 
interactions while the serine-prolin-rich domain is most likely a target for PTM (89). 
14
DNA!polymerase!???an!enzyme!with!many!functions
Pol/????????????????????????????????????????????????????????????????????????????????????????????????????????relatively/inaccurate/when/acting/on/longer/stretches/of/undamaged/DNA/and/are/mainly/implicated/in/the/repair/??????????????????????????????????????????????????????????? ??????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????
?????????????????? ?????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????? ????? ?????? ????????? ?????????????????????????????????????????
structure/of/Pol/??????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????????????Figure/1?????????????????????
???????????????????????????????????????????/like/core/of/Pol/?/and/Pol/????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????? ?????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
???????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????
Figure#1:#Schematic#presentation#of#the#subdomains#of#DNA#polymerase#?.
??????????????????????????????????????????????????????????????/was/implicated/to/play/a/role/mainly/in/DNA/repair/
???????????????????????????????????????????????????????????? ???????????????????????? ???????????????????????????????????
immunostaining/in/mice/showed/Pol/??????????????????????????????????????????????????????????????????????????????????
????????????????????????????????????????????????????????????????????????????????/were/found/to/be/highest/during/the/
???????????????? ???????????????????????????????????????????????????? ?????????????????????????????????????????????????
into/meiotic/DNA/repair.
?????????????????????????/knockout/mice/were/somewhat/contradictory./A/publication/by/Kobayashi/et/al??????????????????
????????????Pol?/C/C?????????????????????????????????????????????????????????????????????????????????????????????????????
Pol/??????????????????????????????????????????????????????????????? ???????????????????????????????????????????? ????
??????????????????????????????????????????????????2O2???? ????????????????????????????????????????????????????????
that/the/targeting/approach/used/in/this/study/did/not/only/knock/out/Pol/???????????????????????????????????????????
genomic/analysis/predicted/the/existence/of/a/transcribed/gene/that/is/strongly/conserved/throughout/evolution/on/the/
strand/opposite/of/Pol/?./Thus/the/observed/phenotype/was/most/probably/not/only/due/to/a/lack/of/the/original/target/
Pol/?????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
domain/of/Pol/?????????????????????????????????????????????????????? ????????????????????????????????????????????????????
?????????????????????????????????????????????????????????????????????????????????????????????????????????et/al./A/report/
by/Bertocci/et/al/stated/that/Pol/???????????????????????????????????????????????????????????????????????????????????????
??????????????????????????????????????????????????????????????????????????????????????????????????????????????????
Follow<up/work/provided/evidence/that/Pol/??????????????????????????????????????????????/knockout/mice/displayed/a/
????????????????????????????????????????????????????????????????????????????????????? ???????????????????????????
Pol?/C/C???????????????????????????????????????????????????????????????????????/does/not/appear/to/contribute/to/DNA/
???????????????????????????????????????????????????????????????Pol?/C/C/primary/MEFs/towards/oxidative/stress/</as/induced/
??????????????????????????2/</was/revealed./This/sensitivity/manifested/itself/in/a/reduced/number/of/cells/entering/S/
????????????????????????????????????????????????????????????????????????????????????????????????????????????????????
elevated/expression/of/senescence<associated/?<galactosidase./This/senescence/could/be/avoided/by/growing/the/cells/at/
Figure 6: Linear diagram of the full length DNA polymerase l. 
Reproduced from (92) . For details see text.
DNA Pol l was shown to be involved in BER, translesion synthesis (TLS) and non- 
homologous-end-joining (NHEJ) (1,89,93-97). The first result connecting DNA Pol l 
with BER showed DNA Pol l -/-  mouse embryonic fibroblasts (MEF) to be hypersensitive 
against oxidative stress (98). A follow up study revealed that DNA Pol l can serve in a 
backup BER mechanism in DNA Pol l -/- cells (95). In 2007 Maga et al. found that DNA 
Pol l, together with its co-factors PCNA and RP-A, incorporates the correct C about 
1200 fold more efficient opposite a 8-oxo-G lesion than the wrong A (39), highlighting 
the crucial role of DNA Pol l in the repair of oxidative DNA damage. PCNA and RP-A act 
s a m lecular switch to allow the faithful repair of 8-oxo-G by DNA Pol l and bl ck at 
the same time the recruitment of DNA Pol b to the lesion (99). 
DNA Pol l was shown to be able to perform TLS of an AP site following the synthe-
sis by DNA Pol e up to the this site (97). Additionally DNA Pol l can help to bypass a  
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8-oxo-G:C mispair (100). Since DNA Pol d pauses at this site a switch to DNA Pol l is 
required to overcome the lesion.
The role of DNA Pol l was also confirmed in vivo showing that DNA Pol l together with 
MutYH localizes at the sites of DNA damage allowing the MutYH initiated LP-BER to 
take place (40). The recruitment of DNA Pol l was shown to be regulated by interplay 
between PTM (67) and will be discussed in detail in the following. Consistent with its 
predicted role as repair factor in the S-phase of the cell cycle the DNA Pol l level were 
found to be highest in late S and G2 phase. 
Maga et al. could recently show that the activity DNA Pol l is also required for the cell 
cycle progression (101). Knock down of DNA Pol l led to replication fork stress and  
S phase checkpoint activation, what can have detrimental consequences for the cell.
3.6. Ubiquitination
3.6.1. Ubiquitin as posttranslational modification
Since its discovery in the late 1970s (102) the role of ubiquitination has been stud-
ied intensively and was mainly associated with the targeting of misfolded proteins to 
proteasomal degradation. In the mean time a lot of studies were published reporting 
that ubiquitin modulates many other cellular processes like DNA repair (103), receptor 
endocytosis (104,105), apoptosis (106) and autophagy (107).
Ubiquitin is a 76 amino acid peptide that is attached reversibly to its substrate by an 
isopeptide or amide bond. Ubiquitin is mainly attached to K residues of the target 
protein but recent results showed that also the binding to free a-NH2 groups (108) or 
cysteine residues (109) is possible. Ubiquitin can be attached either as mono-, di- or 
polymer. The linkage between the single moieties can be mediated by all seven K resi-
dues present in ubiquitin: K6, K11, K27, K29, K33, K48 and K63, whereas K48 and K63 
are the best characterized (110). 
Ubiquitin is synthesized as inactive precursor protein (111). Before an ubiquitin moiety 
can be attached to a substrate it needs to be activated in an ATP dependent reaction 
that is carried out in a three enzyme based reaction. The ubiquitin-activating enzyme 
(E1) adenylates ubiquitin at the C-terminus, leading to the formation of a high reactive 
thioester bond. The thioester is further transferred to the ubiquitin-conjugating (E2) 
enzyme and finally the ubiquitin ligase (E3) specifically attaches the ubiquitin to the 
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respective substrate (Figure 7) via an isopeptide linkage between the C-terminus and 
the e-amino-group of the K residue. The deubiquitination of proteins is mediated by 
another class of enzymes, the so called deubiquitinases (DUB) that cleave isopeptide 
bonds. 
coupled receptors Ste2 and Ste3 [10,11], and the ABC
transporter proteins [12]. Now, many other plasma mem-
brane proteins of yeast are known to require Ub for their
internalization [2], suggesting that the Ub tag functions
as an internalization signal in Saccharomyces cerevisiae.
Although the role played by Ub in protein internalization
in higher eukaryotes seems to bemore complex and not as
general as in yeast, several well-studied examples are
described below.
Epidermal growth factor receptor
The epidermal growth factor receptor (EGFR) is a recep-
tor tyrosine kinase (RTK) family member activated by
ligand binding. EGFR is ubiquitinated by the E3 ligase
c-Cbl following ligand-dependent phosphorylation of the
receptor [13] as a pre-requisite for its downregulation
(see the review by Dikic in this issue). This process
involves the recruitment of the adaptor protein CIN85
[14] and the endocytic regulatory protein endophilin
[15,16]. Similar mechanisms involving c-Cbl in hepa-
tocyte growth factor receptor internalization have also
been reported [17], whereas distinct Cbl-related
Ub-ligases have been implicated in downregulating other
membrane proteins [18,19].
An interesting twist to the Ub/EGFR story comes from
studies of the protein Eps15 (EGFR pathway substrate
clone 15). Eps15 was originally identified as a phosphor-
ylation substrate of EGFR and was later shown to be
essential for endocytosis [20]. Eps15 is made up of three
Eps15-homology (EH) domains and several peptide
motifs, including two copies of the recently described
UIM (Ub-interactionmotif) [21]. Polo et al. [22] showed
that the Eps15 UIMs interact with Ub. These UIMs are
also required for the mono-ubiquitination of Eps15 at
lysine residues outside of the UIM, possibly mediated
by the Ub-ligase Nedd4 [22,23,24]. The UIMs of other
endocytic proteins such as epsin are similarly required for
their own mono-ubiquitination reactions [22,24]. Inter-
estingly, the adaptor protein CIN85 (which lacks UIMs) is
also mono-ubiquitinated, but in this case c-Cbl itself
seems to be involved the Ub modification [14].
The internalization of growth hormone receptor (GHR)
has also been connected to Ub [25]. However, unlike
other signaling receptors, GHR internalization requires
the recruitment of the Ub-conjugationmachinery, but not
Figure 2
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An overview of the cycle of Ub and Ubl modifier protein metabolism. The
attachment of modifier proteins (Ub or Ubl proteins, [mod]) to a substrate
protein begins with an E1 enzyme that activates the modifier so it can be
linked through a thioester bond to an E2 conjugating enzyme. E2 enzymes
can directly transfer the modifier onto a substrate protein, usually in
cooperation with an E3 ligase enzyme that selects particular substrates.
The modifiers themselves can also be substrates. In the case of Ub, one of
four lysine residues can be used in formation of the iso-peptide bond,
leading to a chain of Ub proteins (red). De-ubiquitinating enzymes (Dub)
cleave covalently attached Ub to allow its reuse.
Table 1
Ubl proteins and their functions.
‘Alternative’ modifier Function References
SUMO (SMT3 in yeast, Ubl1, sentrin, GMP1 or PIC-1) Targets proteins to the nucleus;
frequently involved in regulating transcription
[42]
Nedd8 (Rub1 [related to Ub] in yeast) Regulates the SCF (Skip1/Cullin/F-box) Ub ligases [43]
Hub1 (homologous to Ub) Plays a role in cell polarity processes in yeast [44]
ISG15 (interferon stimulated gene of 15 kDa) or
UCRP (Ub cross-reactive protein)
Implicated in the regulation of interferon signaling [45]
Apg12 (autophagy-12) Regulates the ‘cytoplasm-to-vacuole’
targeting and autophagy pathways
[46]
186 Cell regulation
Current Opinion in Cell Biology 2003, 15:184–190 www.current-opinion.com
Figure 7: Overview of the ubiquitination cycle. 
Reproduced from (112). For details see text.
The substrate specificity in this process is given mainly by the E3’s, what is also reflect-
ed by the variety of this enzyme class. Whil  just t o E ’s and bou  30 E2’s, more than 
600 E3 enzymes were identified so far in humans.
There are two main classes of E3 ligases, the homologous to the E6AP carboxyl 
terminus (HECT) and the really interesting new gene (RING) domain containing ligases. 
Two zinc ions in the RING domain bind the substrate and the E2 enzyme and bring 
them together to facilitate the ubiquitin transfer. In contrast to the HECT domain con-
taining E3 ligases these ones act just as an adaptor of the reaction. The HECT domain 
contains an N-terminal active cysteine (C) residue to that the ubiquitin is transferred. 
The substrate binds to the C-terminus of the dom in and is brought together with the 
ubiquitin by movement of the HECT domain (113). To get the two parts of the domain 
in close proximity movements of up to 50 Å are required (114).
Depending on the length and the linkage of the ubiquitin chains the modification can 
have different consequences for the target. Mono-ubiquitination was shown to be 
mainly involved in endocytosis and transcriptional regulation (113). Ubiquitin linked via 
K63 is involved in cellular processes such as DNA repair and signal transduction (115), 
Introduction                                                       Regulation of the Human MutYH DNA Glycosylase by Ubiquitination
45
while ubiquitin attached by  K48 leads to the proteasomal degradation, if the chains 
have a length of at least four ubiquitin moieties (116).
The proteasome degrades ubiquitinated proteins and releases ubiquitin moieties and 
peptide fragments. It is a huge protein complex consisting of 50 subunits and has a to-
tal size of 2.4 mDa. The 26S proteasome is composed of the 20S and the 19S subunits. 
The 19S subunit is mainly responsible for the recognition of ubiquitin chains. After its 
binding the substrate is transported in the core particle. The 20S subunit is built up of 
four stacked rings that form a tube like structure containing the proteolytic chamber 
in the middle. In the active core the substrate can either be cleaved after hydrophobic, 
acidic or basic residues thereby guaranteeing the degradation of almost every peptide 
sequence (117).
Ubiquitination not only causes proteasomal degradation but was also shown to regu-
late the subcellular localization of a protein. The localization of the MEK1 kinase is 
modulated by crosstalk of ubiquitination and SUMOylation (small ubiquitin like modi-
fier). While the latter leads to re-localization of MEK1 from the nucleus to the cyto-
plasm, ubiquitination maintain the enzyme inactive and kept in the nucleus (118). The 
opposite effect was observed for the von Hippel-Landau tumor suppressor protein 
(119). The SUMOylated protein stays predominantly in the nucleus whereas ubiquiti-
nation causes cytoplasmic localization and protein degradation.
Taken together ubiquitination is a powerful tool not only to regulate the levels of a 
protein, but also its function and localization.
3.6.2. Ubiquitination in base excision repair
Several reports already link ubiquitination with DNA damage repair. Besides its role in 
double strand break repair (DSB) (reviewed in (120)) and TLS (reviewed in (121)) recent 
reports established ubiquitination to be an important regulatory mechanism in BER. 
Mule was identified to be the E3 ubiquitin ligase responsible for the ubiquitination of 
different members of BER. 
Upon exposure to oxidative stress DNA Pol b gets monoubiquitinated by Mule (122), 
what marks the protein for polyubiquitination and subsequent proteasomal degra-
dation (123). Dianov et al. could show that, as long as DNA Pol b, XRCC1 and DNA 
ligase III are parts of an active repair complex on chromatin, they are protected from 
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ubiquitination (123). Thereby a mechanism is guaranteed how the cell can modulate 
the levels of repair proteins as a function of the amount of DNA damage.
For DNA Pol l the regulation was shown to depend on the interplay between phos-
phorylation and ubiquitination. DNA Pol l is a target of the CDK2/cyclin A kinase (124), 
that protects the protein from becoming ubiquitinated by Mule (67) and subsequently 
degraded. Thus DNA Pol l is stabilized in late S- and G2 phase of the cell cycle, at the 
time when the repair capacity of DNA Pol l is needed most.
Consistently, Mule itself is regulated in a DNA damage dependent manner. One regula-
tor of Mule is the alternative reading frame (ARF) protein that accumulates upon oxi-
dative stress and leads to the degradation of Mule (125). A second, ARF independent 
regulation mechanism for Mule was recently discovered involving an isoform of the 
ubiquitin specific processing protease 7 (USP7), USP7S (126). Upon exposure of cells 
to oxidative stress USP7S is down regulated and favors thereby the self-ubiquitination 
of Mule leading to degradation. 
These regulation mechanisms ensure, that as consequence of DNA damage the E3 
ligase Mule is either inactivated by ARF or degraded and BER enzymes thus are stabi-
lized to act at the sites of damage. Consequently DNA repair leads to a reduction in ARF 
and an elevated Mule activity (Summarized in Figure 8). A tight regulation is urgently 
needed since BER activity is continuously required and the cell must react quickly to 
small changes in the amount of DNA damage to prevent deleterious mutations.
Figure 8: Regulation of steady state levels of BER en-
zymes by Mule. 
Reproduced from (127). For details see text.
increased DNA damage repair. This in turn results in a
reduced level of DNA lesions, reduced release of ARF,
activation of Mule and ubiquitylation-dependent degrad-
ation of BER enzymes (Pols b and  (73,77)), thus
completing a whole cycl of DNA damage signaling and
modulation of BER proteins required for DNA repair
(Figure 4). Theoretically, the cellular pool of BER
enzymes should include several components: (i) newly
synthesized proteins located in the cytoplasm, (ii)
enzymes relocated to the nucleus but not yet associated
with chromatin and (iii) chromatin-associated proteins
involved in DNA repair. The dynamics of this pool are
controlled by the cytoplasmic protein Mule, and the
nuclear protein ARF that acts as a messenger reporting
on the state of DNA repair and controlling Mule activity.
Correspondingly, the steady-state levels of BER enzymes
are determined by a dynamic equilibrium of all these
processes (72,73).
ARF LINKS DNA DAMAGE SIGNALING, REPAIR
AND REPLICATION
Although the exact mechanism of ARF induction by
DNA damage is still unclear, recent studies support the
idea that ARF is a DNA damage reporter (74,75). As we
discussed above, ARF interacts with Mule, inhibits
its activity and thus up regulates the flow of BER
enzymes into the nucleus to support efficient DNA
repair (Figure 4). Indeed, it was shown that ARF
knockdown by siRNA reduces the rate of DNA repair,
while Mule deficiency stimulates it (73). However, it was
also demonstrated that ARF induction delays cell cycle
progression through the inhibition of the two E3 ubiquitin
ligases Mule and Mdm2, which promote p53 ubiquityla-
tion and prot asomal degradation n the absence of DNA
damage (76). Taken together, these data indicate that
ARF links DNA damage repair and DNA replication.
On DNA damage, ARF is induced and thus enhances
BER activity through inhibition of Mule and simultan-
eously, by licensing p53 accumulation, delays DNA repli-
cation and cell cycle progression to allow more time for
the cell to accomplish DNA repair (Figure 5).
CONTROLLING BER MECHANISMS BY
POSTTRANSLATIONAL MODIFICATIONS:
FUTURE CHALLENGES
It is evident that the most relevant and elegant way to
regulate BER proteins is through various PTMs. These
can influence BER proteins at different levels: (i) at the
activity level, (ii), at the protein stability level, (iii) at the
protein–protein interaction level, (iv) at the cellular local-
ization lev l, (v) at he tran criptional level and (vi) at
the chromatin level. The main PTMs in the regulation of
BER proteins identified to date include phosphorylation,
acetylation, ubiquitination, SUMOylation and methyla-
tion (Supplementary Table S1 and references therein).
Although exciting, at the moment this is still an
emerging area with many interesting, but disconnected,
observations that have not yet been integrated into a com-
prehensive picture of BER regulation. Nevertheless, some
interesting crosstalks between different BER PTMs have
been discovered.
As an example for such a crosstalk between two PTMs,
we describe the data from our two laboratories on the
Figure 4. Regulation of steady-state levels of BER enzymes by Mule,
CHIP E3 ligases and ARF. Newly synthesized BER proteins are either
transported to the nucleus to take part in DNA repair or, if not
required for DNA repair, they are ubiquitylated by Mule and then
targeted for proteasomal degradation after CHIP-mediated
polyubiquitylation. However, following detection of DNA damage,
ARF is accumulated and inhibits the activity of Mule, thus reducing
BER protein degradation and up regulating nuclear levels of BER
enzymes, which elevates DNA repair. Consequently, the repair of
DNA damage will result in a decreased release of ARF and a concomi-
tantly increased activity of Mule that down regulates BER protein
levels. A new adjustment cycle will therefore begin on the detection
of increased levels of DNA damage. Adapted from ref. 73.
Figure 5. BER is a part of the p53-ARF network controlling genetic
stability. BER activity and DNA replication delay are regulated by the
same proteins. Detection of DNA damage results in the accumulation
of ARF, which activates two cellular processes. By inhibiting Mule, it
stabilizes BER proteins and activates DNA repair. At the same time,
inhibition of Mule and Mdm2 by ARF leads to an accumulation of p53
and results in a cell cycle delay. After DNA repair is accomplished, the
reduction in DNA damage initiates a reverse cycle by reducing DNA
repair and releasing the cell for replication.
Nucleic Acids Research, 2013, Vol. 41, No. 6 3487
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3.7. The E3 ligase Mule
Mule was shown to be involved in many cellular processes as proliferation (128), DNA 
replication (129) and DNA repair (67,122).
It is a member of the HECT domain containing E3 ligases (128). The catalytically active 
domain of the 482 kDa protein is located at the C-terminal 350 amino-acids. A crystal 
structure (Figure 9) (130) of Mule revealed that the HECT domain itself is distributed 
in two subdomains that are connected by a flexible linker. One part contains the ac-
tive C residue while the other one is responsible for binding the E2 enzyme. Further, 
the HECT domain contains a single a-helix, that was shown to be indispensable for 
the stability of the enzyme and its knock down enhances the self ubiquitination of 
Mule. This fact can be explained by the higher flexibility of the protein facilitating the 
ubiquitination reaction.
The N-terminal domains of Mule are involved in interactions with other proteins. The 
ubiquitin associated domain (UBA) binds ubiquitin chains (131) while the WWE (132) 
and the BH3 domain are believed to mediate the binding of interaction partner. The 
function of the two armadillo repeat like (ARLD) domains remains so far elusive (133).
Figure 9: Domains of the Mule E3 ligase and structure of its HECT domain. 
Reproduced from (134). For details see text.
which has been proposed to interact with that of the ubiquitin
molecule [9]. The Mule protein also contains a WWE domain
(residues 1617–1678) which was predicted to be involved in pro-
tein–protein interactions [10]. There is also a highly conserved
BH3 domain (residues 1976–1990) that provides networking inter-
actions for the pro- and anti-apoptotic members of the Bcl-2 family
of proteins and two domains of unknown function named ARLD1
(104–374) and ARLD2 (424–815) for Armadillo repeat-like do-
mains [11]. Although the domain organization of Mule is well
determined, the biological functions these domains are involved
in are still unknown and more work is required in this direction.
Consistent with complex domain organisation and the protein
size, the Mule E3 ligase has been shown to regulate the stability
of multiple substrates, thus playing a role in various physiologi-
cally important processes, such as cell proliferation, DNA replica-
tion and DNA repair. A truncated version of the Mule protein
(named UREB1) was originally shown to bind the p53 tumor sup-
pressor protein and to inhibit its transactivation [12,13]. Only rel-
atively recently has the full length Mule protein been first
identified by two independent research groups. Mule was shown
to be involved in the functioning of the ARF tumor suppressor
and consequently named ARF binding protein 1 (ARF-BP1) [2],
and was also found to play a role in the regulation of the Mcl-1
anti-apoptotic protein through ubiquitylation and was conse-
quently named Mule after Mcl-1 ubiquitin ligase E3 [11]. Other
substrates of Mule have since been discovered and include his-
tones [14], the c-Myc [15] and N-Myc [16] oncoproteins, the
Cdc6 component of pre-replication complexes[17], TopBP1 topoi-
somerase II binding protein[18], DNA polymerase b [19], Miz1
transcription factor [20] and the Rev-erba heme receptor [21].
2. Mule functions in regulation of cell cycle progression
p53 plays a central role in the regulation of the cellular DNA
damage response [22–24]. In unstressed cells the level of p53 is
very low since it is down-regulated, mainly through Mdm2 ubiqui-
tylation and consequent proteasomal degradation [22,25–28]. DNA
damage induces accumulation of the Mdm2 inhibitor ARF (also
known as p14 in human cells and p19 in mouse cells) that conse-
quently leads to p53 accumulation and activation of the DNA
damage response [29]. However, it was also noted that ARF plays
a p53-independent tumor suppressor function since it can also in-
duce proliferation delay in cells that lack a functional p53 or p21
[30–32]. In an attempt to investigate the p53-independent role of
ARF, Wei Gu’s laboratory first over-expressed and then pulled
down tagged ARF from mammalian cells and mass spectrometry
analysis of the proteins identified Mule as a major ARF binding
partner [2]. Since it is known that ARF regulates p53 levels, they
suggested that Mule is a mediator of the ARF effect on p53. They
further demonstrated that Mule directly ubiquitylates the p53 pro-
tein and thus promotes its proteasomal degradation and that ARF
is a strong inhibitor of Mule ubiquitylation activity [2]. This is a
very important finding that mechanistically links Mule to the
DNA damage response.
3. The role of Mule in DNA repair and maintenance of genome
stability
Intriguingly, besides the role in the regulation of p53 levels,
Mule was also identified as a major player involved in regulation
of base excision repair (BER) proteins. BER enzymes are involved
in the processing of a wide spectrum of endogenous and exogenous
DNA lesions, including sites of base loss, non-bulky base lesions
and DNA single strand breaks (SSBs) of different complexity [33]
and alterations in BER lead to genomic instability and cancer (re-
viewed in [34]). BER is initiated by damage specific DNA glycosy-
lases that recognize and release the corrupted base by hydrolysis
of the N-glycosylic bond linking the DNA base to the sugar phos-
phate backbone. The arising abasic site (AP-site) is further pro-
cessed by AP-endonuclease 1 that cleaves the phosphodiester
bond 50- to the AP-site, generating a SSB with a 50-sugar phosphate.
This SSB is then repaired by a DNA repair complex that includes
DNA polymerase b (Pol b), XRCC1 and DNA ligase IIIa (Lig 3). Pol
b possesses AP lyase activity that removes the 50-sugar phosphate
and also, functioning as a DNA polymerase, adds one nucleotide to
the 30-end of the arising single-nucleotide gap. Finally, Lig 3 seals
the DNA ends, therefore accomplishing DNA repair (reviewed in
[33]). This pathway is commonly referred to as the short patch
BER pathway, through which human cells are accomplishing the
majority of BER [35,36].
Fig. 1. Structure of the Mule protein. Schematic representation of the Mule protein indicating several domains and its 3D-structure (PDB code 3H1D) showing a few
important structural elements required for protein activity and its stability (as described in [8]).
2832 S.V. Khoronenkova, G.L. Dianov / FEBS Letters 585 (2011) 2831–2835
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         In the following manuscript, in which I am the first author, the regulation of the        
         DNA glycosylase MutYH by ubiquitination was identified. Further a dependency      
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ABSTRACT	  	  
Oxidation	   of	   DNA	   is	   a	   frequent	   and	   constantly	   occurring	   event.	   One	   of	   the	   best-­‐characterized	  
oxidative	  DNA	   lesions	   is	   7,8-­‐dihydro-­‐8-­‐oxoguanine	   (8-­‐oxo-­‐G).	   It	   instructs	  most	  DNA	  polymerases	   to	  
preferentially	   insert	   an	   adenine	   (A)	   opposite	   8-­‐oxo-­‐G	   instead	   of	   the	   appropriate	   cytosine	   (C)	   thus	  
showing	  miscoding	   potential.	   The	  MutY	  DNA	   glycosylase	   homologue	   (MutYH)	   recognizes	  A:8-­‐oxo-­‐G	  
mispairs	  and	  removes	  the	  mispaired	  A	  giving	  way	  to	  the	  canonical	  base	  excision	  repair	  that	  ultimately	  
restores	  undamaged	  guanine	   (G).	  Here	  we	  show	  that	  human	  MutYH	   is	  ubiquitinated	   in	  vitro	   and	   in	  
vivo	  by	  the	  E3	  ligase	  Mule.	  The	  MutYH	  levels	  depend	  on	  the	  amount	  of	  expressed	  Mule.	  Furthermore	  
MutYH	  and	  Mule	  physically	   interact.	  Ubiquitination	  of	  MutYH	  occurs	  between	  amino-­‐acids	  475-­‐535.	  
Mutation	  of	  the	  five	  lysines	  in	  this	  region,	  significantly	  stabilizes	  MutYH,	  suggesting	  that	  these	  are	  the	  
amino-­‐acids	   used	   for	   ubiquitination	   of	   MutYH.	   We	   found	   that	   an	   ubiquitination-­‐deficient	   MutYH	  
mutant	  showed	  enhanced	  chromatin	  binding.	  The	  mutation	  frequency	  of	  the	  ovarian	  cancer	  cell	  line	  
A2780,	  analyzed	  at	  the	  HPRT	   locus	  was	  dependent	  on	  the	  Mule	   levels	  and	  could	  be	   increased	  upon	  
oxidative	  stress.	  
In	  summary	  our	  data	  show	  that	  ubiquitination	  is	  an	  important	  regulatory	  mechanism	  for	  the	  essential	  
MutYH	  DNA	  glycosylase	  in	  human	  cells.	  
INTRODUCTION	  
Every	  organism	  is	  exposed	  to	  high	  levels	  of	  oxidative	  stress	  every	  day,	  due	  to	  a	  variety	  of	  endogenous	  
and	  exogenous	  sources.	  One	  of	  the	  most	  often	  observed	  consequences	  is	  the	  formation	  of	  the	  highly	  
mutagenic	   lesion	   7,8-­‐dihydro-­‐8-­‐oxoguanine	   (8-­‐oxo-­‐G),	   that	   arises	   approximately	   103	   times	   per	   cell	  
and	  day	   in	  normal	   tissue	  and	  up	  to	  105	  times	   in	  cancer	  tissues	   (1).	  The	  8-­‐oxo-­‐G	   lesion	   is	  potentially	  
highly	  mutagenic,	  since	  replicative	  Pols	  tend	  to	  incorporate	  the	  incorrect	  A	  rather	  than	  the	  correct	  C	  
opposite	   the	   lesion,	   leading	   to	   the	   formation	   of	   an	   A:8-­‐oxo-­‐G	   mispair.	   If	   these	   mispairs	   are	   not	  
repaired	   before	   the	   next	   replication	   cycle,	   GC-­‐>TA	   transversion	   mutations	   occur.	   Such	   mutations	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were	   found	   to	   be	   frequently	   present	   in	   different	   types	   of	   cancer	   tissues	   (2),	   demonstrating	   the	  
paramount	   importance	   for	   the	   organism	   of	   a	   mechanism	   ensuring	   the	   correct	   repair	   of	   8-­‐oxo-­‐G	  
lesions.	  As	  we	  have	  previously	  shown	  (3,	  4),	  such	  a	  mechanism	  indeed	  exists.	  It	  is	  a	  specialized	  base	  
excision	   repair	   (BER)	   pathway	   coordinated	   by	   the	   glycosylase	  MutYH	   and	  DNA	   polymerase	   (Pol)	  λ.	  
MutYH	  recognizes	  a	  mispaired	  A	  and	  excises	  it,	  leading	  to	  the	  formation	  of	  a	  one	  nucleotide	  gap,	  still	  
bearing	  the	  8-­‐oxo	  G	  lesion	  on	  the	  template	  strand,	  that	  is	  subsequently	  filled	  by	  Pol	  l.	   In	  contrast	  to	  
other	  Pols,	  Pol	  λ	  and	  to	  some	  extent	  Pol	  η,	  both	  in	  the	  presence	  of	  proliferating	  cell	  nuclear	  antigen	  
(PCNA)	  and	  replication	  protein	  A	  (RP-­‐A),	  are	  very	  efficient	  in	  the	  correct	  bypass	  of	  an	  8-­‐oxo-­‐G	  lesion	  
thereby	  preventing	  the	  generation	  of	  mutations	  (3).	  	  
In	   agreement	   with	   the	   important	   role	   of	   MutYH	   in	   the	   repair	   of	   oxidative	   DNA	   damage,	   mouse	  
embryonic	  fibroblasts	  as	  well	  as	  embryonic	  stem	  cells	  derived	  from	  MutYH	  -­‐/-­‐	  mice	  show	  an	  increase	  
in	  mutation	  frequency	  (4,5).	  Furthermore,	  knockout	  mice	  have	  a	  higher	  incidence	  of	  tumor	  formation	  
compared	  to	  the	  wild	  type	  mice.	  This	  effect	  can	  even	  be	  increased	  by	  exposing	  the	  mice	  to	  an	  oxidant	  
showing	  that	  the	  absence	  of	  MutYH	  drastically	  impairs	  the	  repair	  of	  oxidative	  damage	  (6).	  Intriguingly,	  
MutYH	  transcript	  levels	  are	  inversely	  correlated	  with	  the	  survival	  outcome	  of	  patients	  suffering	  from	  
gastric	  cancer	  (7).	  
The	   BER	   machinery	   needs	   to	   be	   tightly	   controlled	   to	   ensure	   an	   efficient	   and	   correct	   repair	   of	  
damaged	   DNA.	   Already	   small	   differences	   in	   expression	   of	   individual	   BER	   proteins	   can	   disturb	   the	  
entire	   pathway	   and	   thus	   lead	   to	   a	   reduced	   repair	   capacity	   (8).	   Recent	   data	   provide	   evidence	   that	  
regulation	  of	  BER	  is	  mainly	  achieved	  through	  various	  posttranslational	  modifications	  (PTMs),	  such	  as	  
phosphorylation	  and	  ubiquitination	  (9-­‐12).	  The	  steady	  state	  levels	  of	  the	  BER	  members,	  Pol	  β	  and	  Pol	  
λ,	  are	  tightly	  controlled	  by	  ubiquitination	  leading	  to	  proteasomal	  degradation,	  in	  order	  to	  guarantee	  
the	   correct	   repair	   of	   damaged	  DNA	   (reviewed	   in	   (13))	   .	   The	   E3	   ubiquitin	   ligase	   responsible	   for	   the	  
ubiquitination	   of	   Pol	  β	   and	   Pol	  λ,	   was	   identified	   to	   be	  Mule,	   a	   HECT	   domain	   containing	   E3	   ligase	  
involved	   in	  many	   cellular	   processes	   like	   cell	   proliferation,	   DNA	   replication	   and	   repair	   (14).	   On	   the	  
other	  hand,	  very	  little	  is	  known	  about	  the	  PTMs	  of	  MutYH	  and	  their	  potential	  roles	  in	  the	  regulation	  of	  
the	  protein.	  Only	  phosphorylation	  was	  shown	  to	  stimulate	  the	  glycosylase	  activity	  of	  MutYH	  (15).	  
In	  the	  present	  paper	  we	  provide	  the	  first	  evidence	  that	  MutYH	   is	  also	  a	  target	   for	  ubiquitination	  by	  
the	   E3	   ligase	  Mule.	   Ubiquitinated	  MutYH	   is	  marked	   for	   proteasomal	   degradation	   thereby	   not	   only	  
modulating	   the	   protein	   level	   itself	   but	   also	   the	   intracellular	   distribution	   of	   the	   protein.	   We	  
furthermore	  show	  that	  a	  tight	  regulation	  of	  MutYH	  is	  of	  great	  importance,	  since	  altered	  protein	  levels	  
lead	  to	  an	  increase	  in	  mutation	  frequency	  at	  the	  HPRT	  locus	  of	  the	  ovarian	  cancer	  cells	  A2780.	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MATERIAL	  AND	  METHODS	  
Chemicals	  
Oligonucleotides	  for	  site	  directed	  mutagenesis	  were	  purchased	  from	  Microsynth	  and	  KBrO3	  	  
from	  Sigma.	  The	  Mule	  siRNA	  (Hs_HUWE2)	  was	  purchased	  from	  Qiagen.	  
	  
Cells	  and	  Extracts	  
HeLa	   cells	  were	   purchased	   from	  American	   type	   cell	   culture.	   HEK293T	   and	  A2780	   (described	   in	   ref.	  
(16))	  cells	  were	  gifts	   from	  R.	  Santoro	   (University	  of	  Zürich,	  Switzerland),	  and	   J.	   Jiricny	   (University	  of	  
Zürich,	   Switzerland),	   respectively.	   Cells	  were	   grown	   under	   standard	   conditions.	  Whole	   cell	   extracts	  
were	   prepared	   by	   scraping	   cells	   into	   lysis	   buffer	   (10%	   glycerol,	  1%	   Triton	   X-­‐100,	   1,5	  mM	  MgCl2,	  50	  
mM	  Hepes	  (pH	  7,5),	  150	  mM	  NaCl,	  1	  mM	  EGTA,	  100	  mM	  NaF,	  10	  mM	  Na2P2O7,	  1	  mM	  Na3VO4,	  1	  mM	  
PMSF,	  1	  μg/ml	  bepstatin,	  1	  μg/ml	  leupeptin,	  1	  μg/ml	  pepstatin)	  and	  incubated	  for	  5	  min	  on	  ice.	  The	  
cell	  lysates	  were	  sonicated	  at	  4°C	  for	  2.5	  min	  
and	  centrifuged	  for	  10	  min	  at	  15.000	  g.	  The	  supernatants	  were	  collected	  and	  stored	  at	  -­‐80°C.	  
Cell	  fractionations	  into	  cytoplasmic,	  nuclear	  and	  chromatin	  fractions	  were	  performed	  as	  described	  in	  
ref.	  (10).	  
	  
Western	  Blot	  Analysis	  	  
Western	  Blot	  analysis	  was	  performed	  according	  to	  standard	  protocols	  and	  visualized	  by	  the	  Odyssey	  
image	  analysis	  system	  (Li-­‐cor,	  Bioscience).	  
	  
Antibodies	  and	  Proteins	  
The	  antibodies	   (AB)	   against	  MutYH	  and	  GST	  were	  purchased	   from	  St.	   Cruz.	   The	  Mule	  AB	  was	   from	  
Bethyl	  Laboratories,	  the	  tubulin	  AB	  from	  Sigma-­‐Aldrich	  and	  the	  Histone	  H3	  AB	  from	  Abcam.	  The	  Flag	  
AB	  was	  from	  Sigma,	  the	  HA	  AB	  from	  Covance,	  the	  His	  AB	  from	  Qiagen	  and	  the	  Actin	  AB	  from	  Sigma.	  
Recombinant	  MutYH	  was	   expressed	   and	   purified	   as	   described	   in	   ref.	   (17)	   and	   the	  HECT	   domain	   of	  
Mule	  according	  to	  ref.	  (12).	  
	  
RNA	  Interference	  
Cells	   were	   transfected	   using	   Lipofectamin	   RNAiMax	   (Invitrogen)	   according	   to	   the	   manufacturer`s	  
instructions	  and	  harvested	  72h	  after	  transfection.	  
	  
Site	  Directed	  Mutagenesis	  
Site	   directed	   mutagenesis	   was	   performed	   using	   PfuTurbo	   Pol	   from	   Stratagene	   according	   to	   the	  
manufacturer`s	  instructions.	  The	  primers	  (Microsynth)	  were	  designed	  using	  PrimerX.	  
MutYH	  KK477RR:5-­‐GTTTCCACCGCCATGAGAAGGGTTTTCCGTGTGTATC-­‐3	  	  
and	  5-­‐GATACACACGGAAAACCCTTCTCATGGCGGTGGAAAC-­‐3,	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K495R:	  5-­‐CCTGTATGGGTTCCAGAAGGTCCCAGGTGTC-­‐3	  	  
and	  5-­‐GACACCTGGGACCTTCTGGAACCCATACAGG-­‐3,	  
KK506RR:	  5-­‐CCGTGCAGTCGGAGAAGGCCCCGCATGGGCC-­‐3	  	  
and	  5-­‐GGCCCATGCGGGGCCTTCTCCGACTGCACGG-­‐3	  ;	  
HECT	  C326A:	  5-­‐CTGCCTTCAGCTCACACAGCTTTTAATCAGCTGGATC-­‐3	  	  
and	   5-­‐GATCCAGCTGATTAAAAGCTGTGTGAGCTGAAGGCAG3.	   The	   primers	   were	   used	   on	   the	   pcDNA3	  
HA-­‐MutYH	   and	   the	   pcDNA3	   Flag-­‐MuleΔN447	   plasmids	   and	   the	   mutagenesis	   was	   confirmed	   by	  
sequencing.	  
	  
qPCR	  
Total	  RNA	  was	   isolated	   from	  cells	  using	   the	  Nucleo	  Spin	  RNAII	  Kit	   (Macherey	  &	  Nagel),	  RT-­‐PCR	  was	  
performed	  using	  the	  QIAGEN	  OneStep	  RT-­‐PCR	  Kit.	  qPCR	  was	  performed	  using	  SYBR	  Green	  (Qiagen),	  
150	   ng	   of	   total	   RNA	   and	   the	   oligonucleotides	   (Microsynth)	   as	   follows:	   HA-­‐MutYH:	   5-­‐
GCCAGCAAGTCCTGGATAAT-­‐3	   and	   5-­‐ATGCGTAGTCAGGCACGTC-­‐3	   ,MutYH:	   5-­‐
CCAGAGAGTGGAGCAGGAAC-­‐3	   and	   5-­‐TTTCTGGGGAAGTGGACCAC-­‐3	   ,L28:	   5-­‐
GCAATTCCTTCCGCTACAAC-­‐3	  and	  5-­‐TGTTCTTGCGGATCATGTGT-­‐3.	  L28	  was	  used	  as	  internal	  standard.	  
	  
KBrO3	  Treatment	  and	  Cell	  Based	  Mutagenesis	  Assay	  
The	  cell	  based	  mutagenesis	  assays	  were	  performed	  using	  the	  A2780	  cell	  line	  as	  described	  in	  ref.	  (16)	  
Briefly	  the	  cells	  were	  transfected	  with	  plasmid	  or	  siRNA	  as	  indicated	  in	  the	  Figure,	  24h	  later	  the	  cells	  
were	   seeded	   for	   treatment	   with	   KBrO3	   (concentrations	   as	   indicated,	   30	   min).	   After	   culturing	   the	  
treated	  cells	  for	  7	  days,	  they	  were	  reseeded	  and	  cells	  harboring	  a	  mutation	  in	  the	  HPRT1	  gene	  were	  
selected	   by	   adding	   6-­‐TG	   (5	   μg/ml,	   Sigma).	   The	   mutation	   rate	   was	   calculated	   after	   7	   days	   under	  
selection,	  the	  number	  of	  colonies	  was	  normalized	  to	  the	  seeding	  efficiency	  as	  described	  in	  (16).	  
	  
GST	  Pull-­‐Down	  Assay	  
The	  GST	  pull-­‐down	  assay	  was	  performed	  using	   recombinant	   and	  purified	  GST-­‐tagged	  MutYH	   (2	  μg)	  
coupled	   to	  GST-­‐sepharose	  beads	  and	   incubated	  with	  800	  ng	  of	   recombinant	  HECT-­‐domain	  of	  Mule.	  
The	  assay	  was	  performed	  as	  described	  in	  detail	  in	  ref.	  (17).	  
	  
Pull-­‐Down	  Assay	  
Cell	  extract	  containing	  overexpressed	  flag	  tagged	  HECT	  domain	  of	  Mule	  was	  incubated	  with	  flag	  AB	  (1	  
μg)	  and	  25	  ml	  of	  protein	  G	  sepharose	  beads	  (GE	  Healthcare)	  for	  2	  h.	  After	  washing	  three	  times	  with	  a	  
buffer	  containing	  PBS	  with	  0.2%	  Triton,	  X-­‐100,	  1	  mM	  DTT,	  1	  mg/ml	   leupeptin,	  1	  mg/ml	  pepstatin,	  1	  
mg/ml	  bestatin,	   and	  1	  mM	  PMSF	  800	  ng	  of	   recombinant	  purified	  protein	  was	   added	   to	   the	  beads.	  
After	   three	   times	  washing	   the	   beads	  were	   finally	   resuspended	   in	   Laemmli	   buffer	   and	   the	   samples	  
were	  analyzed	  by	  Western	  blotting.	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Detection	  of	  Protein	  Ubiquitination	  
The	  protocol	  was	  used	  to	  eliminate	  all	  non-­‐covalent	  protein	  binding	  and	  was	  performed	  as	  described	  
in	  detail	  in	  ref.	  (18).	  
	  
Co-­‐Immunoprecipitation	  
Cell	  extracts	  were	  prepared	  as	  described,	  1:2	  diluted	  in	  HNTG	  buffer	  (20	  mM	  Hepes	  (pH	  7.5)	  150	  mM	  
NaCl,	  10%	   glycerol	   0,1%	   Triton	   X-­‐100,	   10	  mM	  NaF,	   1	  mM	  Na3VO4)	   and	   incubated	  with	   2	   μg	   AB	   as	  
indicated	   and	   25	   ml	   of	   protein	   G	   sepharose	   beads.	   After	   rotating	   for	   2	   h	   at	   4°C	   the	   beads	   were	  
washed	   three	   times	   with	   HNTG	   buffer,	   finally	   resuspended	   in	   Laemmli	   Buffer	   and	   analyzed	   by	  
western	  blotting.	  
	  
In	  vitro	  Ubiquitination	  Assay	  
In	  vitro	  ubiquitination	  was	  performed	  as	  described	  in	  ref.	  (12).	  Briefly	  the	  assay	  was	  performed	  in	  a	  15	  
μl	   reaction	  mixture	  containing	  E1	  activating	  enzyme	   (0.7	  pmol),	   E2	  conjugating	  enzymes	   (9.5	  pmol)	  
and	  ubiquitin	  (0.6	  nmol,	  Boston	  Chemicals).	  The	  reaction	  was	  carried	  out	  in	  buffer	  containing	  25mM	  
Tris–HCl	  (pH	  8.0),	  4	  mM	  ATP,	  5	  mM	  MgCl2,	  200	  mM	  CaCl2,	  1	  mM	  DTT,	  10	  mM	  MG132	  for	  1	  h	  at	  30°C.	  
Finally,	  Laemmli	  buffer	  was	  added	  and	  the	  samples	  were	  analyzed	  by	  western	  blotting.	  
	  
DNA	  Isolation	  and	  8-­‐oxo-­‐G	  Determination	  
Approximately	   2x107	   cells	  were	   harvested	   and	   immediately	   stored	   at	   -­‐80°C.	   The	  DNA	  was	   isolated	  
with	  the	  DNA	  Isolation	  Kit	  for	  Cells	  and	  Tissues	  (Roche)	  according	  to	  the	  manufacturers	  instructions.	  
The	  8-­‐oxo-­‐G	  determination	  was	  carried	  out	  following	  the	  protocol	  depicted	  in	  ref.	  (19).	  
	  
Microscopy	  
HeLa	  cells	  were	  transfected	  with	  plasmids	  as	  indicated	  using	  Lipofectamin2000	  (Invitrogen)	  according	  
to	   the	   manufacturer`s	   instructions.	   The	   cells	   were	   seeded	   on	   glass	   coverslips	   and	   fixed	   using	  
methanol	   for	   20	  min	   at	   -­‐20°C.	   After	   blocking	   with	   PBS/10%FCS	   the	   cells	   were	   incubated	   with	   the	  
indicated	  primary	  AB	   (1:300	   in	   PBS/10%FCS)	   for	   2	   h.	   The	   coverslips	  were	  washed	   three	   times	  with	  
PBS/10%FCS	  (30	  min),	  incubated	  with	  the	  secondary	  Cy3	  (1:300	  in	  PBS/10%FCS)	  for	  1h,	  washed	  three	  
times	   and	   fixed	  on	  object	   slides	  using	  Vectashield	   (Vector	   labs).	   The	  pictures	  were	   taken	  using	   the	  
Leica	  CTR	  6000.	  
	  
	  
	  
	  
Regulation of the Human MutYH DNA Glycosylase by Ubiquitination                                                                  Original Research Article
54
 
RESULTS	  
MutYH	  is	  Ubiquitinated	  in	  vitro	  and	  in	  vivo	  by	  the	  E3	  Ubiquitin	  Ligase	  Mule.	  
Former	   studies	   identified	   the	   E3	   ubiquitin	   ligase	  Mule	   as	   a	   regulator	   of	   the	   steady	   state	   levels	   of	  
different	   proteins	   involved	   in	   BER	   (10,12,20).	   Here,	   we	   were	   aiming	   at	   the	   identification	   of	   the	  
regulatory	   mechanisms	   controlling	   the	   MutYH	   protein	   levels	   in	   the	   cell.	   Using	   an	   in	   vitro	  
ubiquitination	  approach	  we	  tested	  whether	  MutYH	  was	  a	  substrate	  for	  the	  E3	  ubiquitin	  ligase	  Mule.	  
Mule	   is	   a	   482	   kDa	   protein	   whose	   catalytical	   center	   lies	   in	   the	   homologous	   to	   the	   E6-­‐AP	   carboxyl	  
terminus	   (HECT)	   domain,	   mapped	   to	   the	   C-­‐terminal	   370	   amino	   acids	   of	   Mule	   (21).	   Using	   the	  
recombinant,	   purified	   HECT	   domain	   in	   an	   in	   vitro	   ubiquitination	   assay	   (Figure	   1	   A),	   we	   found	   that	  
MutYH	  got	  ubiquitinated	  by	   the	  HECT	  domain	   in	  presence	  of	   the	  E2	  conjugating	  enzymes	  H5b,	  H5c	  
and	  H7.	  In	  order	  to	  get	  more	  distinct	  bands	  a	  mutant	  ubiquitin,	  not	  able	  to	  form	  poly-­‐ubiquitin	  chains,	  
was	  used	  in	  all	  in	  vitro	  assays.	  	  
We	  next	  addressed	  the	  question	  whether	  Mule	  also	  plays	  a	  role	   in	  the	  regulation	  of	  MutYH	   in	  vivo.	  
We	   transfected	   a	   N-­‐terminal	   deletion	   construct	   of	   Mule	   containing	   the	   full	   HECT	   domain	   (Mule	  
ΔN2474)	  together	  with	  MutYH	  for	  overexpression	  into	  HEK293T	  cells.	  As	  shown	  in	  Figure	  1	  B	  the	  co-­‐
transfection	  led	  to	  the	  appearance	  of	  higher	  migrating	  MutYH	  bands	  (lane	  2	  and	  3)	  in	  contrast	  to	  the	  
control	   (lane	   1)	   in	   which	   just	   one	   form	   of	   MutYH	   was	   present.	   The	   fact	   that	   addition	   of	   the	  
proteasomal	  inhibitor	  MG132	  (lane	  3)	  to	  the	  transfected	  cells	  prior	  to	  harvest	  caused	  an	  increase	  in	  
the	  intensity	  in	  the	  higher	  migrating	  bands	  of	  MutYH,	  further	  suggested	  that	  these	  bands	  represented	  
an	  ubiquitinated	  form	  of	  the	  protein.	  To	  ensure	  that	  the	  catalytic	  activity	  of	  Mule	  was	  required	  for	  the	  
modification	  of	  MutYH,	   the	  experiment	  was	   repeated	  using	  a	   catalytic	  dead	  mutant	  of	  Mule	   (Mule	  
C4341A).	   In	   contrast	   to	   the	   first	   experiment	   using	   the	   Mule	   WT,	   the	   co-­‐transfection	   of	   the	   Mule	  
C4341A	  mutant	  together	  with	  MutYH	  did	  not	  result	  in	  higher	  migrating	  forms	  of	  MutYH	  (Figure	  1	  C).	  	  
	  We	  performed	  a	  transient	  KD	  of	  Mule	   in	  HEK293T	  cells	  (Figure	  1	  D)	  that	  overexpressed	  MutYH	  and	  
ubiquitin.	  After	   inhibition	  of	   the	  proteasomal	  degradation	  by	  adding	  MG132	  we	  purified	  MutYH	  by	  
binding	   to	   beads	   and	   analyzed	   the	   amount	   of	   ubiquitinated	  MutYH	   (Figure	   1	   E).	   The	   KD	   of	   Mule	  
resulted	   in	  a	  50%	  reduction	  of	  modified	  MutYH,	   indicating	   that	  Mule	   is	   the	  enzyme	  responsible	   for	  
ubiquitination	   of	   MutYH	   (Figure	   1	   F).	   The	   observed	   dramatic	   decrease	   in	   the	   formation	   of	  
ubiquitinated	  MutYH	   upon	   knock	   down	   (KD)	   of	  Mule,	   further	   supports	   its	   role	   as	   the	   E3	   ligase	   for	  
MutYH	  ubiquitination.	  
MutYH	  Protein	  Levels	  Depend	  on	  the	  Amount	  of	  the	  E3	  Ubiquitin	  Ligase	  Mule.	  
To	   show	   the	   relevance	   of	   regulation	   by	  Mule	   in	   vivo,	   we	   performed	   a	   transient	   KD	   of	  Mule	   using	  
siRNA	  expecting	  to	  see	  an	  effect	  on	  the	  endogenous	  protein	  levels	  of	  MutYH.	  As	  shown	  in	  Figure	  2	  A	  
and	  B	  the	  KD	  of	  Mule	  led	  to	  a	  significant	  increase	  in	  MutYH	  protein	  level,	  while	  neither	  the	  treatment	  
with	   Lipofectamine	   nor	  with	   scrambled	   (scr)	   siRNA	   showed	   this	   effect.	   Unchanged	  mRNA	   levels	   of	  
MutYH	  upon	  Mule	  KD	  were	  indicative	  that	  the	  regulation	  of	  MutYH	  was	  at	  the	  protein	  level	  (Fig.	  2	  C).	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Consistent	  with	  these	  results	  we	  observed	  the	  opposite	  upon	  Mule	  overexpression.	  The	  transfection	  
of	  HEK293T	  cells	  with	  Mule	  caused	  a	  dramatic	  decrease	  in	  the	  endogenous	  level	  of	  MutYH	  compared	  
to	  the	  empty	  vector	  control	   (Figure	  2	  D	  and	  E).	  As	  expected	  the	  MutYH	  mRNA	   level	  did	  not	  change	  
upon	  overexpression	  of	  Mule	  (Figure	  2	  F).	  These	  results	  led	  us	  to	  conclude	  that	  indeed	  Mule	  is	  the	  E3	  
ubiquitin	  ligase	  responsible	  for	  the	  regulation	  of	  MutYH	  on	  protein	  level	  in	  vivo.	  
MutYH	  and	  Mule	  Physically	  Interact.	  
The	  experiments	  shown	  above,	  while	  strongly	  suggesting	  that	  Mule	  binds	  to	  and	  ubiquitinated	  MutYH,	  
do	  not	  exclude	   the	  possibility	   that	  Mule	  may	   function	  as	   scaffold	  protein,	  bringing	  MutYH	   together	  
with	   other	   proteins,	   ultimately	   responsible	   for	   its	   ubiquitination.	  We	   then	   addressed	   the	   question	  
whether	   MutYH	   and	   Mule	   directly	   interact.	   In	   the	   first	   approach	   we	   could	   confirm	   the	   physical	  
interaction	  between	  the	  two	  proteins	  by	  performing	  pull-­‐down	  assays	  using	  tagged,	  recombinant	  and	  
purified	  proteins.	  The	  pull	  down	  of	  GST-­‐tagged	  MutYH	  also	  enriched	  the	  HECT	  domain	  demonstrating	  
its	   direct	   interaction	  with	  MutYH	   (Figure	   3	  A).	  Moreover,	   the	   pull-­‐down	  of	   the	  HECT	  domain	   using	  
flag-­‐beads	  confirmed	  the	  interaction	  between	  the	  two	  proteins	  (Figure	  3	  B).	  
Finally	   we	   showed	   that	   the	   interaction	   could	   be	   also	   recapitulated	   in	   cells.	   We	   performed	   co-­‐
immunoprecipitation	  experiments	  using	  whole	  cell	  extract	  containing	  overexpressed	  flag-­‐tagged	  Mule	  
and	   HA-­‐tagged	   MutYH.	   By	   binding	   of	   Mule	   to	   flag-­‐beads	   we	   could	   show,	   that	   MutYH	   co-­‐
immunoprecipitated	   (Figure	   3	   C).	   The	   interaction	   could	   be	   also	   confirmed	   vice	   versa	   by	   coupling	  
MutYH	   to	   HA-­‐beads	   and	   analyzing	   the	   samples	   for	   co-­‐immunoprecipitated	   Mule	   (Fig.	   3	   D),	  
strengthening	  the	  point	  that	  Mule	  directly	  ubiquitinates	  MutYH.	  
	  
MutYH	  is	  Ubiquitinated	  Between	  Amino-­‐acids	  475-­‐535	  and	  Mutation	  of	  the	  Five	  Lysine	  Residues	  in	  
this	  Part	  of	  the	  Protein	  Stabilize	  MutYH	  on	  the	  Protein	  Level.	  
Ubiquitin	   chains	   are	   covalently	   attached	   to	   lysine	   residues	   on	   the	   target	   protein.	   The	   sequence	   of	  
MutYH	  reveals	  a	  total	  of	  17	  lysine	  residues	  distributed	  all	  over	  the	  protein,	  with	  an	  accumulation	  on	  
the	   C-­‐	   and	   N-­‐terminal	   sites.	   In	   order	   to	   identify	   the	   lysine	   residues	   that	   are	   the	   targets	   for	  
ubiquitination	   by	   Mule	   we	   generated	   deletion	   constructs	   of	   MutYH	   (Figure	   4	   A):	   one	   construct	  
spanning	   the	  N-­‐terminal	  part	   (amino-­‐acids	  1-­‐350)	   containing	   the	  glycosylase	  domain	  of	  MutYH,	   the	  
other	   construct	   consisting	   of	   the	   C-­‐terminal	  MutT-­‐like	   domain	   (amino-­‐acids	   350-­‐535).	   Using	   these	  
constructs	   in	  an	   in	   vitro	   ubiquitination	  approach	  we	  could	   identify	   the	  MutT	   like	  domain	  of	  MutYH	  
(lane	  6)	  to	  be	  ubiquitinated	  by	  Mule,	  while	  the	  N-­‐terminal	  part	  or	  MutYH	  was	  not	  modified	  (lane	  4,	  
Fig.	   4	   A).	   To	   narrow	   down	   the	   region	   we	   generated	   further	   deletion	   constructs	   of	   the	   MutT-­‐like	  
domain.	  Once	  the	  amino-­‐acids	  475-­‐535	  were	  deleted	  the	  MutYH	  construct	  was	  not	  ubiquitinated	  any	  
more	  (lane	  12	  and	  14)	  leading	  finally	  to	  the	  conclusion	  that	  the	  C-­‐terminal	  60	  amino-­‐acids	  of	  MutYH	  
contain	   the	  ubiquitination	   sites.	   The	   sequence	  of	  MutYH	   (Figure	  4	  B)	   contained	   five	   lysine	   residues	  
within	  this	  region	  as	  potential	  targets	  for	  ubiquitination	  (Figure	  4	  B).	  To	  address	  the	  question	  which	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function	  these	  lysine	  residues	  have	  for	  the	  regulation	  of	  MutYH	  we	  generated	  ubiquitination	  deficient,	  
lysine	   to	   arginine	   point	   mutants:	   KK477RR,	   K495R,	   KK506RR	   and	   one	   construct	   containing	   all	   five	  
lysine	  residues	  mutated	  to	  arginine	  (5R)	  (Figure	  4	  B).	  Consistent	  with	  the	  idea	  that	  ubiquitination	  of	  
MutYH	  affects	   the	  proteasomal	  degradation	  of	  MutYH	  all	   lysine	  point	  mutants	   showed	  stabilization	  
on	   the	   protein	   level	   if	   transfected	   in	   HEK293T	   cells	   (Figure	   4	   C	   and	   D).	   Strikingly,	   the	   5R	   mutant	  
showed	   a	   more	   pronounced	   increase	   in	   protein	   level	   (5-­‐fold	   compared	   to	   WT)	   than	   the	   single	  
mutants	   (1.5	   –	   2.5	   fold)	   (Figure	   4	   C	   and	  D),	   leading	   to	   the	   assumption	   that	   all	   five	   lysine	   residues	  
appear	  to	  contribute	  to	  the	  ubiquitination	  of	  MutYH.	  	  
Ubiquitination	  Deficient	  MutYH	  is	  Preferentially	  Bound	  to	  Chromatin.	  
Besides	   protein	   stability,	   ubiquitination	   can	   also	   influence	   the	   intracellular	   localization	   of	   a	   protein	  
(22).	   To	   figure	   out	  whether	   the	   amount	   of	   ubiquitinated	  MutYH	  determines	   the	   localization	  of	   the	  
protein	   within	   the	   cell,	   cell	   fractionation	   experiments	  were	   performed	   (Figure	   5	   A).	   HEK293T	   cells	  
transfected	  with	  either	  the	  MutYH	  WT	  or	  the	  5R	  mutant	  were	  fractionated	  into	  cytoplasmic,	  nuclear	  
and	  chromatin	  bound	  fractions.	  We	  observed	  that	  the	  ubiquitination	  deficient	  mutant	  of	  MutYH	  was	  
enriched	   in	  the	  chromatin	  bound	  fraction	  with	  respect	  to	  the	  WT	  (Figure	  5	  B),	  while	  the	  amount	  of	  
MutYH	  in	  the	  cytoplasm	  remained	  comparable	  (Figure	  5	  C).	  This	  effect	  could	  be	  further	  confirmed	  by	  
using	  an	  immunocytochemistry	  approach.	  HeLa	  cells	  were	  transfected	  with	  the	  HA-­‐tagged	  MutYH	  WT	  
or	   the	  5R	  mutant	  and	  stained	   for	  HA	  and	   the	  nuclear	  marker	  DAPI	   (4',6-­‐Diamidino-­‐2-­‐Phenylindole).	  
The	  result	  clearly	  showed	  that	  the	  MutYH	  WT	  was	  exclusively	  localized	  in	  the	  cytoplasm	  while	  the	  5R	  
mutant	  was	  also	  present	   in	   the	  nucleus	   to	  a	   substantial	  amount	   (Figure	  5	  D).	  Taken	   together	   these	  
results	  clearly	  showed	  that	  ubiquitination	  of	  MutYH	  not	  only	  influences	  its	  turnover	  but	  also	  changed	  
its	  subcellular	  localization.	  
ROS	  Treatment	  Increases	  the	  8-­‐oxo-­‐G	  Levels	  and	  the	  Mutation	  Frequency	  in	  A2780	  Ovarian	  Cancer	  
Cells.	  
MutYH	  plays	  an	   important	  role	   in	  the	  repair	  of	  8-­‐oxo-­‐G	  thereby	  preventing	  the	  onset	  of	  deleterious	  
mutations	   (23,24).	   Consequently	   we	   expected	   changes	   in	   the	   mutation	   frequency	   to	   happen	  
according	  to	  the	  amount	  of	  MutYH	  present	  in	  the	  cells.	  To	  stimulate	  the	  formation	  of	  8-­‐oxo-­‐G	  lesions	  
A2780	   cells,	   either	   transfected	  with	   a	  Mule	   construct	   (Mule	  ΔN2474)	   or	  Mule	   siRNA,	  were	   treated	  
with	  KBrO3.	  From	  Figure	  6	  A	  it	  is	  evident	  that	  the	  8-­‐oxo-­‐G	  levels	  in	  the	  cells	  increased	  upon	  treatment	  
with	  increasing	  amounts	  of	  KBrO3,	  as	  determined	  in	  a	  mass	  spectrometry	  based	  assay.	  The	  observed	  
levels	   of	   8-­‐oxo-­‐G	  are	   in	   accordance	  with	   the	  numbers	   reported	   in	   literature	   (data	  not	   shown),	   The	  
results	  showed	  a	  clear	  tendency	  that	  the	  treatment	  with	  KBrO3	  resulted	  in	  a	  higher	  oxidative	  burden	  
for	  the	  cell.	  
We	  have	  already	  shown	  above	   the	  dependency	  of	  MutYH	   levels	  on	   the	  amount	  of	  Mule	   (Figure	  2).	  
Such	  relationship	  was	  also	  confirmed	  in	  the	  A2780	  cell	  system.	  Figure	  6	  B	  clearly	  shows	  an	  increase	  of	  
endogenous	   MutYH	   protein	   levels	   upon	   KD	   of	   Mule	   and,	   conversely,	   a	   decrease	   upon	   Mule	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overexpression.	   The	   mutation	   frequency	   at	   the	   HPRT	   locus	   in	   these	   cells	   was	   also	   analyzed	   by	  
selection	  with	  6-­‐Thioguanine	  (6-­‐TG),	  a	  toxic	  guanine	  analogue.	  Mule	  KD	  cells	  had	  a	  higher	  MutYH	  level	  
(Figure	   6	   B)	   and	   a	   lower	   incidence	   of	  mutations	   in	   the	   HPRT	   locus	   (Figure	   6	   C).	   The	   opposite	  was	  
observed	  for	  the	  Mule	  (Mule	  ΔN2474)	  overexpressing	  cells,	  showing	  a	  decrease	  in	  MutYH	  level	  with	  
respect	  to	  the	  control	  (Figure	  6	  B	  and	  C).	  
These	  data	   confirmed	   the	  hypothesis	   that	   the	  Mule	  dependent	   regulation	  of	  MutYH	   influences	   the	  
susceptibility	   of	   cells	   to	  mutagenesis	   caused	   by	   exposure	   to	   oxidative	   stress.	   This	   clearly	   indicated	  
that	  the	  regulation	  of	  MutYH	  has	  a	  direct	  impact	  on	  the	  mutation	  frequency	  in	  cells,	  underlining	  again	  
the	  importance	  of	  a	  tight	  and	  controlled	  regulation	  of	  the	  BER	  machinery.	  
DISCUSSION	  
In	   this	   work	   we	   provide	   evidence	   that	   ubiquitination	   regulates	   not	   only	   the	   steady	   state	   levels	   of	  
MutYH,	  but	  also	  its	  subcellular	  localization.	  We	  identify	  Mule	  to	  be	  the	  E3	  ubiquitin	  ligase	  responsible	  
for	  the	  modification	  of	  MutYH.	  Mule	  mainly	  appears	  to	  monoubiquitinate	  MutYH.	  Whether	  other	  E3	  
ubiquitin	   ligases	  are	   involved	   in	   the	  polyubiquitination	  and	  proteasomal	  degradation	  remains	  so	   far	  
elusive.	  Consistent	  with	  the	  predicted	  role	  of	  Mule	  in	  the	  proteasomal	  degradation	  of	  MutYH,	  we	  find	  
the	  MutYH	  protein	  levels	  to	  be	  reversely	  correlated	  with	  the	  levels	  of	  Mule	  present	  in	  HEK	  293T	  cells.	  
Five	  lysine	  residues	  could	  be	  identified	  as	  targets	  for	  ubiquitination	  by	  Mule.	  The	  clear	  stabilization	  of	  
the	   ubiquitination-­‐deficient	   MutYH	   mutants	   confirms	   the	   role	   that	   they	   are	   playing	   in	   the	  
proteasomal	  degradation	  of	  the	  protein.	  
The	  enzymatic	  activity	  of	  MutYH	  needs	  to	  be	  directed	  to	  the	  nucleus	  in	  order	  to	  act	  upon	  the	  newly	  
synthesized	   strand	   immediately	   after	   replication,	   to	   prevent	   the	   formation	   of	   deleterious	   G:C-­‐>T:A	  
transversion	   mutations	   (26,27).	   Our	   data	   implicate	   that	   the	   ubiquitination	   of	   MutYH	   plays	   an	  
important	   role	   in	   enrichment	   of	   MutYH	   on	   chromatin.	   We	   observed	   that	   mutation	   of	   the	  
ubiquitination	   sites	   result	   in	   strong	   accumulation	   of	   MutYH	   in	   the	   chromatin	   bound	   cell	   fraction,	  
respectively	   in	   the	   nucleus	   as	   shown	   by	   immunofluorescence.	   We	   previously	   found	   that	   the	  
recruitment	  of	  Pol	  λ	  to	  chromatin	  is	  mediated	  by	  interplay	  of	  ubiquitination	  and	  phosphorylation	  as	  
well	  as	  by	  formation	  of	  active	  repair	  complexes	  on	  chromatin	  (10,28,29).	  Comprising	  the	  recent	  data	  
it	  seems	  very	   likely	  that	  MutYH	  might	  coordinate	  the	  MutYH/Pol	  λ	  dependent	  LP-­‐BER	  pathway	  (17).	  
Whether,	   like	   for	  Pol	  λ,	   it	   is	  an	  orchestration	  of	  different	  PTM	  adjusting	   the	  subcellular	   localization	  
and	  protein	  levels	  of	  MutYH	  remains	  to	  be	  elucidated.	  
As	   noted	   in	   the	   literature	   a	   cell	   contains	   1000-­‐7000	   8-­‐oxo-­‐G	   as	   a	   steady	   state	   level	   that	   can	   be	  
repaired	   any	   time	   (25).	   MutYH	   has	   an	   important	   role	   in	   the	   repair	   of	   these	   lesions,	   thus	   mis-­‐
regulation	  or	  mutations	  of	  the	  enzyme	  cause	  an	  increased	  mutation	  frequency	  (8,30).	  In	  accordance	  
we	   see	   differences	   in	   the	   mutation	   frequency	   depending	   on	   the	   levels	   of	   MutYH.	   In	   general	   the	  
mutation	   frequency	  at	   the	  HPRT	   locus	   increases	  upon	  KBrO3	   treatment	  of	  A2780	  cells.	   Further,	   the	  
data	  suggest	  that	  cells	  with	  elevated	  MutYH	  levels,	  due	  to	  KD	  of	  Mule,	  are	  better	  able	  to	  cope	  with	  
oxidative	  stress	  than	  cells	  with	  a	  lower	  amount	  of	  MutYH,	  upon	  Mule	  overexpression.	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In	   conclusion,	   the	   data	   presented	   here	   underline	   again	   the	   importance	   of	   a	   tight	   and	   controlled	  
regulation	  of	  BER,	   since	  already	   small	   differences	   in	  protein	   levels	   can	  have	  a	  pivotal	   effect	  on	   the	  
genome	   integrity.	   In	   line	   with	   previous	   results,	   showing	   BER	   enzymes	   to	   be	   regulated	   by	   PTM	   to	  
ensure	  a	  faithful	  repair	  of	  8-­‐oxo-­‐G	  lesions,	  we	  observed	  for	  the	  first	  time	  a	  similar	  regulation	  for	  the	  
essential	  MutYH	  DNA	  glycosylase.	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FIGURES	  LEGENDS	  
Figure	  1.	  MutYH	  is	  ubiquitinated	  in	  vitro	  and	  in	  vivo	  by	  the	  E3	  ubiquitin	  ligase	  Mule.	  
(A)	   In	  vitro	  ubiquitination	  of	  MutYH	  by	  the	  recombinant	  and	  purified	  HECT	  domain	  of	  Mule.	   (B)	  Co-­‐
transfection	  of	  Flag-­‐Mule	  ΔN2474	  and	  HA-­‐MutYH	  into	  HEK293T	  cells.	  The	  cells	  were	  treated	  with	  10	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mM	  MG132	  for	  16	  h	  prior	  to	  harvest.	  (C)	  Co-­‐transfection	  of	  Flag-­‐Mule	  ΔN2474	  C4341A	  and	  HA-­‐MutYH	  
into	  HEK293T	  cells.	  The	  cells	  were	  treated	  with	  10	  mM	  MG132	  for	  16	  h	  prior	  to	  harvest.	  (D)	  Mule	  KD	  
in	  HEK293T	  cells,	  analyzed	  by	  Western	  blotting.	  5%	  of	  total	  cell	  extracts	  were	  loaded	  as	  input	  from	  E.	  
(E)	   Immunoprecipitation	   of	   Flag-­‐Mule	   ΔN2474,	   co-­‐transfected	   with	   HA-­‐Ubiquitin.	   The	   cells	   were	  
treated	  with	  Mule	  siRNA	  (efficiency	  confirmed	  in	  D)	  or	  scr	  siRNA	  as	  indicated	  and	  the	  samples	  were	  
analyzed	   by	   Western	   blotting.	   (F)	   Quantification	   of	   E.	   The	   amount	   of	   ubiquitinated	   MutYH	   was	  
normalized	  to	  the	  amount	  of	  unmodified	  Flag-­‐MutYH	  bound	  to	  the	  beads.	  
Figure	  2.	  MutYH	  protein	  levels	  depend	  on	  the	  amount	  of	  the	  E3	  ubiquitin	  ligase	  Mule.	  (A)	  The	  effect	  
of	  Mule	  KD	  in	  HEK293T	  cells,	  analyzed	  by	  Western	  blotting.	  (B)	  Quantification	  of	  protein	  levels	  shown	  
in	   A.	   The	   protein	   levels	   of	  MutYH	  were	   normalized	   to	   tubulin.	   (C)	   Quantification	   of	  MutYH	  mRNA	  
extracted	  from	  the	  samples	  shown	  in	  A.	  The	  MutYH	  mRNA	  was	  normalized	  to	  the	  levels	  of	  L28	  mRNA.	  
(D)	  The	  effect	  of	  Flag-­‐Mule	  ΔN2474	  overexpression	  in	  HEK	  293T	  cells,	  analyzed	  by	  Western	  blotting.	  
(E)	   Quantification	   of	   protein	   levels	   shown	   in	   D.	   The	   protein	   levels	   of	   MutYH	   were	   normalized	   to	  
tubulin.	   (F)	  Quantification	  of	  the	  MutYH	  mRNA	  extracted	  from	  the	  samples	  shown	  in	  D.	  The	  MutYH	  
mRNA	  was	  normalized	  to	  the	  levels	  of	  L28	  mRNA.	  
Figure	   3.	  MutYH	   and	  Mule	   physically	   interact.	   (A)	   GST-­‐pulldown	   of	   GST-­‐MutYH	  with	  His-­‐HECT.	   The	  
recombinant	  and	  purified	  proteins	  were	   incubated	  with	  GST-­‐beads.	   (B)	  Pulldown	  of	   Flag-­‐HECT	  with	  
GST-­‐MutYH.	  Flag	  AB	  coupled	  beads	  were	   incubated	  with	  cell	  extracts	  containing	  Flag-­‐HECT,	  washed	  
and	   incubated	  with	   the	   recombinant	   and	   purified	  GST-­‐MutYH.	   (C)	   Co-­‐immunoprecipitation	   of	   Flag-­‐
Mule	   ΔN2474	   with	   HA-­‐MutYH.	   Whole	   cell	   extracts	   containing	   the	   overexpressed	   proteins	   were	  
incubated	  with	  Flag	  AB	  coupled	  to	  beads.	  (C)	  Co-­‐immunoprecipitation	  of	  Flag-­‐Mule	  ΔN2474	  with	  HA-­‐
MutYH.	   Whole	   cell	   extracts	   containing	   the	   overexpressed	   proteins	   were	   incubated	   with	   HA	   AB	  
coupled	  to	  beads.	  The	  band	  marked	  with	  an	  asterisk	  (*)	  corresponds	  to	  the	  MutYH	  signal,	  the	  lower	  
band	  is	  an	  unspecific	  signal	  from	  IgG.	  
Figure	   4.	   MutYH	   is	   ubiquitinated	   between	   amino-­‐acids	   475-­‐535	   and	   mutation	   of	   the	   five	   lysine	  
residues	  in	  this	  part	  of	  the	  protein	  stabilize	  MutYH	  on	  the	  protein	  level.	  (A)	  In	  vitro	  ubiquitination	  of	  
different	   recombinant	   and	   purified	   MutYH	   deletion	   constructs,	   as	   depicted	   in	   the	   upper	   part.	   (B)	  
Amino-­‐acid	   sequence	  of	  MutYH	  between	  position	  475	  and	  535.	  Highlighted	  are	   the	  K	   residues	   that	  
were	  mutated	  into	  R.	  (C)	  Transfection	  of	  the	  MutYH	  point	  mutant	  constructs	  (as	  indicated)	  into	  HEK	  
293T	   cells,	   analyzed	   by	  Western	   blotting.	   (D)	   Normalization	   of	   the	  mutant	  MutYH	   protein	   level	   as	  
shown	   in	   C	   to	   the	   mRNA	   level	   of	   the	   respective	   expression	   construct.	   The	   protein	   levels	   were	  
normalized	  to	  actin	  and	  the	  mRNA	  level	  to	  L28	  mRNA.	  
Figure	   5.	   Ubiquitination	   deficient	   MutYH	   is	   preferentially	   bound	   to	   chromatin.	   (A)	   Transfection	   of	  
MutYH	  WT	  or	  5R	  mutant	   into	  HEK	  293T	  cells.	  The	  cells	  were	   fractionated	  and	  analyzed	  by	  Western	  
blotting.	   (B)	  Quantification	  of	   the	  MutYH	  protein	   level	   in	   the	  chromatin	  bound	  fraction	  shown	   in	  A.	  
The	  protein	  levels	  were	  normalized	  to	  the	  histone	  H3.	  (C)	  Quantification	  of	  the	  MutYH	  protein	  level	  in	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the	   cytoplasmic	   fraction	   shown	   in	   A.	   The	   protein	   levels	   were	   normalized	   to	   the	   tubulin.	   (D)	  
Fluorescence	  microscope	  images	  of	  HeLa	  cells	  transfected	  with	  MutYH	  WT	  or	  the	  5R	  mutant.	  The	  cells	  
were	  fixed	  and	  stained	  with	  HA	  AB	  and	  DAPI.	  
Figure	   6.	   ROS	   treatment	   increases	   the	   8-­‐oxo-­‐G	   level	   and	   the	  mutation	   frequency	   in	  A2780	   ovarian	  
cancer	  cells.	  (A)	  A2780	  cells	  were	  treated	  with	  increasing	  amounts	  of	  KBrO3,	  the	  DNA	  was	  isolated	  and	  
analyzed	   for	   8-­‐oxo-­‐G	   as	   described	   in	  Material	   and	  Methods.	   (B)	   Effect	   of	  Mule	   KD	   and	   Flag-­‐Mule	  
ΔN2474	  overexpression	  in	  A2780	  cells,	  analyzed	  by	  Western	  blotting.	  (C)	  Mutation	  frequency	  at	  the	  
HPRT	  locus	  in	  A2780	  cells,	  either	  treated	  with	  Mule	  siRNA	  or	  transfected	  with	  Flag-­‐Mule	  ΔN2474	  and,	  
as	  indicated,	  incubated	  with	  increasing	  amounts	  of	  KBrO3.	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5. Unpublished data
5.1. Interaction studies of DNA polymerase λ
5.1.1. Interaction of DNA polymerase λ and Ogg1 DNA glycosylase
DNA Pol l was shown to interact with many enzymes involved in DNA damage repair, 
like PCNA (135) and MutYH (40). To investigate whether Ogg1 is also a binding partner 
of DNA Pol l co-immunoprecipitation experiments were performed. Whole cell ex-
tracts were generated either out of HEK293T or HeLa cells and endogenous DNA Pol l 
was coupled to beads using DNA Pol l antibody (AB). As shown in Figure 10 Ogg1 was 
co-precipitated in both cell lines confirming an interaction between the two proteins. 
Whether the interaction is direct or rather mediated by another binding partner re-
mains was not tested.
Figure 10: Interaction of DNA Pol λ and Ogg1.
DNA Pol l AB coupled beads were used to immunoprecipitate DNA Pol l from either HEK293T or 
HeLa whole cell extract. Binding of Ogg1 was analyzed by Western blotting.
Since many protein interactions are modulated by PTMs the influence of phosphory-
lation on the interaction between DNA Pol l and Ogg1 was addressed. Co-immuno-
precipitation experiments from HEK293T whole cell extracts were performed either 
in the presence or absence of phosphatase inhibitors. The inhibition of phosphatase 
activity in the cell extracts led to a dramatic decrease in the binding of Ogg1 to DNA 
Pol l, suggesting a dependency on phosphorylation (Figure 11 A). To confirm this re-
sult in another approach the Pol l coupled beads were incubated with calf intestine 
phosphatase (CIP) prior to analysis of Ogg1 binding. As shown in Figure 11 A and B also 
the removal of phosphate residues on the bound proteins influenced the interaction. 
Consistent with the first result the interaction between DNA Pol l and Ogg1 appears 
to be stronger in the absence of phosphorylation.
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Figure 11: The interaction between DNA Pol l and Ogg1 is phosphorylation dependent. 
(A) Coimmunprecipitation of DNA Pol λ and Ogg1 from HEK293T whole cell extract. (B) Quantification 
of the data shown in A.
Discussion
DNA Pol l plays an important role in the repair of 8-oxo-G lesions that can arise from a 
variety of endogenous and exogenous sources. In contrast to the replicative Pols DNA 
Pol λ is able to incorporate the correct C opposite a 8-oxo-G lesion thereby prevent-
ing the formation of G:C->T:A transversion mutations (99). Subsequently the resulting 
8-oxo-G:C pair is a substrate for the DNA glycosylase Ogg1 that can excise the lesion. 
An interaction between DNA Pol λ and Ogg1 might facilitate the repair of the lesion 
by directing the executing glycosylase to the site of damage. DNA repair processes 
need to be tightly regulated to prevent any unintentional action. The binding of DNA 
Pol l to Ogg1 seems to be regulated by phosphorylation. The results presented here 
are in accordance with previous findings showing that phosphorylation of DNA Pol l 
regulates the steady state levels of the protein by interfering with the ubiquitination 
of the protein (67). Taken together these results show that BER is regulated by inter-
play between different PTM modulating not only the presence of repair complexes on 
chromatin but also the interaction between proteins. 
To gain further insides in the regulation of BER it would be of great interest to inves-
tigate which enzymes under which conditions are involved in the phosphorylation of 
DNA Pol l.
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5.1.2. Interaction of DNA polymerase l and MutYH DNA glycosylase
MutYH was shown to be an interaction partner of DNA Pol l (40), but so far it was not 
determined which part of MutYH is involved in the binding. To address this question 
further different GST-tagged deletion constructs of MutYH were cloned, expressed and 
purified (Figure 12).
Figure 12: Scheme of MutYH dele-
tion constructs used for pulldown 
experiments.
The MutYH constructs were used to perform GST-pulldown experiments with recom-
binant and purified DNA Pol l. As shown in Figure 13 DNA Pol λ co-precipitated with 
the full length MutYH (lane 8) as well as with the N-terminal part of MutYH (lane 5). An 
interaction could not be detected neither with a construct missing the very N-terminal 
130 amino-acids (lane 6) nor with the C-terminal part of MutYH (lane 7). These results 
led to the conclusion that the interaction site is located within in the N-terminal 130 
amino-acids of MutYH.
Figure 13: GST-pulldown of MutYH and DNA Pol l. 
The pulldown was performed under the conditions described in section 4. 
Regulation of the Human MutYH DNA Glycosylase by Ubiquitination                                                                  Unpublished Data
72
To narrow the region involved in the interaction further down another MutYH deletion 
construct (40-535) was included in the experiment (Figure 14). The result in Figure 14 
showed that this construct was able to bind DNA Pol l (lane 8) leading to the conclu-
sion that the N-terminal amino-acids 40-130 of MutYH mediated the interaction with 
DNA Pol l.
Figure 14: GST-pulldown of MutYH and DNA Pol l. 
The pulldown was performed under the conditions described in section 4. 
 Unpublished Data                                                    Regulation of the Human MutYH DNA Glycosylase by Ubiquitination
73
Mutations in MutYH were shown to have an important impact on the onset of colorec-
tal cancer. Germline mutations in many positions of MutYH were identified in patients 
suffering from MAP (136). Among those are two missense mutations within the region 
40-130, V61E and W117R. To investigate whether these mutations influence the bind-
ing to DNA Pol l point-mutation constructs of MutYH were tested. As can be seen in 
Figure 15 neither the V61E (lane 7) nor the W117R (lane 8) mutant showed a changed 
in the binding capacity to DNA Pol l with respect to the MutYH WT (lane 9).
Figure 15: GST-pulldown of MutYH point mutants V61E and W117R and DNA Pol λ. 
The pulldown was performed under the conditions described in section 4. 
Discussion
If replication occurs before 8-oxo-G lesions are removed by Ogg1 the formation of 
8-oxo-G:A mispairs is very likely. In this case MutYH can recognize and remove the 
mispaired A. Subsequently DNA Pol l is able to incorporate the correct C opposite the 
lesion thereby giving the cell another chance to repair the lesion correctly. The inter-
action of DNA Pol l and MutYH was already described in the context of the MutYH 
initiated LP-BER pathway (40). The results presented here confirm this interaction and 
specify the amino-acids 40-130 of MutYH to be essential for the binding of DNA Pol 
l. Two point mutations that were identified in MAP patients are located within this 
region but do no seem to affect the interaction. Since the catalytically active site is 
located in the N-terminal part of MutYH it would be interesting to investigate whether 
these mutations have any impact on the glycosylase activity.
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5.2. Stability of MutYH
The proteasomal degradation of many proteins is mediated by binding to other pro-
teins or protein-complexes (123,137). MutYH is a central player of the BER and inter-
acts with proteins involved in DNA damage repair processes (reviewed in (138)). Based 
on the findings reported before (section 4) it was further examined whether the pro-
teasomal degradation of MutYH is modulated by the interaction with other proteins. A 
screen using siRNA against Rad1, DNA ligase 1, DNA Pol l, APE1, PCNA, PARP1, Rad9, 
Hus1, Ogg1, XRCC1 and MSH6 showed that only the depletion of XRCC1 led to a dra-
matic reduction of MutYH on protein level (Figure 16). 
Figure 16: XRCC1 depletion causes a decrease in MutYH level.  
Knock down was performed in HEK293T cells using siRNA as indicated. The experiment was per-
formed under the conditions described in section 4. and analyzed by Western blotting.
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This result could be further confirmed as shown in Figure 17 A and B. The regulation 
of MutYH upon XRCC1 took place on protein level since the mRNA remained almost 
unchanged (Figure 17 B). This result indicates that also the interaction with other pro-
teins might contribute to the stabilization and protection of MutYH from proteasomal 
degradation.
Figure 17: XRCC1 knock down causes a decrease of MutYH on protein level. 
(A) XRCC1 knock down was performed under the conditions described in section 4. and analyzed 
by Western blotting. (B) Quantitative PCR analysis of the samples presented in A. The MutYH mRNA 
level were normalized to L28.
Discussion
The formation of protein complexes not only serves as functional link between en-
zymes but can also protect their members from proteasomal degradation. The steady 
state levels of DNA Pol β as well as DNA ligase III were shown to be modulated by bind-
ing to XRCC1 (123,139). The interaction with XRCC1 renders the proteins in both cases 
more stable and protected from proteasomal degradation. XRCC1 is an important scaf-
fold protein able to bind AP sites and to facilitate the repair process by coordinating 
the executing enzymes (140). Thus it is very likely that also the susceptibility of MutYH 
to proteasomal degradation might be regulated in a similar manner. Further experi-
ments would be required to show whether a direct interaction between XRCC1 and 
MutYH is taking place, thus explaining the stabilizing effect. 
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6. Summary of the main findings
In order to give a clear overview of the main findings disclosed in this thesis a short 
summary is given below.
• The E3 ligase Mule ubiquitinates MutYH in vitro and in vivo.
• Mule knock down leads to an increase in endogenous MutYH protein levels.
• Mule overexpression causes a decrease in MutYH protein levels.
• Mule and MutYH interact physically.
• The ubiquitination sites of MutYH are located within the amino-acids 475-535.
• The ubiquitination deficient mutant of MutYH is stabilized on protein level.
• The ubiquitination deficient mutant of MutYH is predominantly bound to   
 chromatin.   
• Treatment with KBrO3 increases the 8-oxo-G levels and the mutation frequen- 
 cy at the HPRT locus in the ovarian cancer cells A2780.
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7. Discussion
Many enzymes involved in DNA damage repair are targets for PTM that can influence 
the function, protein level or subcellular localization of the enzymes (141). But so far 
just few studies investigated how these regulatory mechanisms are cross-linked with 
each other. Since DNA damage can occur all the time repair enzymes are needed per-
manently to ensure the genomic integrity. Consistently BER enzymes are rather “fine 
tuned” on the steady state level than completely “shut on or of” (127).
In this thesis it is shown for the first time, how the DNA glycosylase MutYH is regulated 
on protein level. Mule was identified to be the E3 ligase responsible for the ubiqui-
tination of MutYH. In an in vitro assay it could be shown that MutYH is a target for 
the modification mediated by Mule. This result could be further confirmed in whole 
cell extracts exhibiting that this reaction can also take place in a normal cellular con-
text. Mule was shown to mainly monoubiquitinate its substrates what stimulates the 
subsequent polyubiquitination of the proteins (123,142). Therefore it would be very 
interesting to investigate whether MutYH is also a target of polyubiquitination stimu-
lated by Mule and mediated by another E3 ligase. This question could be addressed by 
fractionation of whole cell extracts and isolation of the E3 activity containing fractions.
The levels of Mule in cells dramatically influenced the amount of MutYH protein levels 
while the amount of mRNA remained unchanged. These results serve as “proof of prin-
ciple” that Mule is the E3 ligase modulating the MutYH levels in cells. Since Mule was 
shown to be regulated upstream by factors induced by oxidative stress (134) it would 
be interesting to analyze the effect that exposure to oxidative stress has on the protein 
levels of MutYH.
Mule and MutYH interact, as shown by co-immunoprecipitation performed out of 
whole cell extracts. To confirm a direct interaction and to exclude the binding via an-
other scaffold protein pull-down experiments with recombinant and purified enzymes 
were performed with the same results.
To identify the sites of ubiquitination different deletion constructs of MutYH were used 
in an in vitro ubiquitination assay with Mule. The results identified five lysine residues 
located in the C-terminal part of the protein as targets for modification. Consistently all 
arginine point mutants of these sites were stabilized on protein level. The stabilization 
of the mutant having all lysine residues mutated was clearly the strongest, implicat-
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ing that at least to a certain extend all five lysine residues can be ubiquitinated and 
replaced by each other.
Strikingly the ubiquitination deficient mutant of MutYH was shown not only to be sta-
bilized but also to be predominantly bound to chromatin implicating that ubiquitina-
tion not only controls the protein levels of MutYH but also its activity on damaged 
DNA. This result is in accordance with previous publications confirming an important 
role for ubiquitination in the subcellular localization of proteins (118). Since the de-
ubiquitinated MutYH is located on the chromatin it would be interesting to investigate 
whether the modification also affect the glycosylase activity or the DNA binding capac-
ity.
MutYH is an important enzyme in BER and its inactivation or mutation was shown to 
impair the DNA damage repair and thereby to increase the mutation frequency in dif-
ferent tissues and cell lines (143). 
Consistently with these findings the treatment of A2780 ovarian cancer cells with 
KBrO3 increased the mutation frequency analyzed at the HPRT locus. This effect can 
be explained by the elevated levels of 8-oxo-G following the treatment as determined 
by mass spectrometry. Strikingly it was found that Mule knock down cells, showing 
elevated levels of MutYH, can cope better with the high levels of 8-oxo-G formation 
than the Mule overexpression cells with decreased MutYH levels. To follow this line it 
would be interesting to see how cells expressing the ubiquitination deficient mutant of 
MutYH behave upon exposure to oxidative stress.
Taken together the results presented in this thesis identified another regulatory mech-
anism that allows the cells to regulate the DNA damage repair. However a lot of effort 
needs to be done to gain more insights into the subtle regulation of the BER enzymes 
and to understand how all of these pathways interact with and influence each other to 
enable the cell finally to react properly to oxidative damage.
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